<SEC-DOCUMENT>0001213900-26-019383.txt : 20260223
<SEC-HEADER>0001213900-26-019383.hdr.sgml : 20260223
<ACCEPTANCE-DATETIME>20260223170027
ACCESSION NUMBER:		0001213900-26-019383
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20260218
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260223
DATE AS OF CHANGE:		20260223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OLB GROUP, INC.
		CENTRAL INDEX KEY:			0001314196
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				133712553
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39435
		FILM NUMBER:		26666159

	BUSINESS ADDRESS:	
		STREET 1:		1120 AVENUE OF THE AMERICAS
		STREET 2:		4TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-278-0900

	MAIL ADDRESS:	
		STREET 1:		1120 AVENUE OF THE AMERICAS
		STREET 2:		4TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0277771-8k_olbgroup.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:OLB="http://olb.com/20260218">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_OLB_olb.com_20260218 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20260218_20260218 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001314196 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000004" name="dei:EntityCentralIndexKey">0001314196</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="olb-20260218.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-02-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314196</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-02-18</xbrli:startDate>
        <xbrli:endDate>2026-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20260218__20260218_zwe2GgbtAhI7"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Pursuant to Section&#160;13 or Section&#160;15(d)
of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_901_edei--DocumentPeriodEndDate_c20260218__20260218_zkIsJrXLp4gi"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February
18, 2026</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_906_edei--EntityRegistrantName_c20260218__20260218_zKn28c7kNFi9"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000011" name="dei:EntityRegistrantName">THE OLB GROUP, INC.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20260218__20260218_zKTxFUpfHob9"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityFileNumber_c20260218__20260218_zZolEfdmrOuk"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000013" name="dei:EntityFileNumber">001-39435</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20260218__20260218_zI1ysR34yfna"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000014" name="dei:EntityTaxIdentificationNumber">12-4188568</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(IRS Employer<br/>
Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20260218__20260218_zUjBZjKtswba"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000015" name="dei:EntityAddressAddressLine1">1120 Avenue of the Americas</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20260218__20260218_zQsQOSXorO4h"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000016" name="dei:EntityAddressAddressLine2">4th Floor</ix:nonNumeric></span><br/>
<span id="xdx_90B_edei--EntityAddressCityOrTown_c20260218__20260218_zIJkt29LJGZi"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000017" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20260218__20260218_zf887ssNcbY5"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000018" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20260218__20260218_zdnzz2937Iz3"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000019" name="dei:EntityAddressPostalZipCode">10036</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&#8217;s telephone number, including area
code: <b>(<span id="xdx_901_edei--CityAreaCode_c20260218__20260218_zdTV8SJWF0P7"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000020" name="dei:CityAreaCode">212</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20260218__20260218_z8JveWIDZIfb"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000021" name="dei:LocalPhoneNumber">278-0900</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since last
report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20260218__20260218_zbvYlyJQpgc9"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20260218__20260218_z3ihYYAup00b"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementTenderOffer_c20260218__20260218_zQSgpV9LAjug"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20260218__20260218_zZPbnjnShYgd"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities registered pursuant to Section&#160;12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20260218__20260218_zPcj2MFjz85h"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20260218__20260218_zbBVlfhjLoba"><ix:nonNumeric contextRef="AsOf2026-02-18" id="Fact000027" name="dei:TradingSymbol">OLB</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SecurityExchangeName_c20260218__20260218_zSe9IQSkltPa"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of
the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Emerging growth company&#160;<span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20260218__20260218_zgwjUfGk39F4"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section&#160;13(a) of the Exchange Act. <span id="xdx_907_edei--EntityExTransitionPeriod_c20260218__20260218_zO8YHIsJyQJ4"><ix:nonNumeric contextRef="AsOf2026-02-18" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 18, 2026, The
OLB Group, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with an
institutional investor (the &#8220;Purchaser&#8221;) pursuant to which the Company agreed to sell and issue, in a private placement offering,
(i) pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to 2,857,142 shares of the Company&#8217;s common stock,
par value $0.0001 per share (the &#8220;Common Stock&#8221;) (the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants,
the &#8220;Pre-Funded Warrant Shares&#8221;) and (ii) common warrants (the &#8220;Warrants&#8221;) to purchase up to 3,571,428 shares
of Common Stock (the shares of Common Stock issuable upon exercise of the Warrants, the &#8220;Warrant Shares&#8221;), at a combined purchase
price per Pre-Funded Warrant and accompanying Warrants of $1.05 (inclusive of the exercise price of $0.0001 to be paid upon exercise of
each Pre-Funded Warrant) (the &#8220;Offering&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Pre-Funded Warrants are immediately
exercisable, will expire upon exercise in full of all Pre-Funded Warrants and have an exercise price of $0.0001. The Warrants will be
exercisable upon the Effective Date (as defined in the Purchase Agreement), will expire on the five-year anniversary of the Effective
Date (as defined in the Purchase Agreement), and have an exercise price of $0.92 per share. The aggregate gross proceeds to the Company
from the Offering were approximately $3.0 million, before deducting placement agent fees and other offering expenses. The Offering closed
on February 19, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
customary representations, warranties, and agreements by the Company and the Purchaser, customary conditions to closing, and customary
indemnification obligations of the Company. Pursuant to the terms of the Purchase Agreement, until forty-five (45) days after the Closing
Date (as defined in the Purchase Agreement), subject to certain exceptions, the Company may not issue, enter into any agreement to issue
or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement).
The Company, subject to certain exceptions, also may not effect or enter into an agreement to effect an issuance by the Company or any
of its subsidiaries of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement), or a combination of units thereof,
involving a Variable Rate Transaction (as defined in the Purchase Agreement) until six (6) months following the Effective Date; provided
however, that after forty-five (45) days after the Effective Date, the entry into and/or issuance of shares of Common Stock in an &#8220;at
the market&#8221; offering shall not be deemed a Variable Rate Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, pursuant to the
Purchase Agreement, the Company agreed to reduce the exercise price to $0.92 and extend the term for three years until February 19, 2029
of certain outstanding warrants issued to the Purchaser on August 23, 2021 and November 8, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the Purchase
Agreement, on February 18, 2026, the Company also entered into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;)
with the Purchaser. Pursuant to the Registration Rights Agreement, the Company will be required to file a resale registration statement
(the &#8220;Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register the Pre-Funded
Warrant Shares and Warrant Shares for resale. The Company agreed to file the Registration Statement within 15 calendar days following
the Company&#8217;s filing of its Annual Report on Form 10-K, and to have such Registration Statement declared effective within 30 days
following the filing date (or, in the event of a &#8220;full review&#8221; by the SEC, within 60 calendar days following the filing date.
The Company will be obligated to pay liquidated damages to the Purchaser if the Company fails to file the Registration Statement when
required or fails to cause the Registration Statement to be declared effective by the SEC when required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Pre-Funded Warrants, Warrants,
Pre-Funded Warrant Shares and Warrant Shares were not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;),
and were offered pursuant to an exemption from the registration requirements of the Securities Act provided under Section 4(a)(2) of the
Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">D. Boral Capital LLC (&#8220;D.
Boral&#8221;) acted as exclusive placement agent in connection with the Offering pursuant to that certain placement agency agreement,
dated February 18, 2026 (the &#8220;Placement Agency Agreement&#8221;), by and between the Company and D. Boral. Pursuant to the Placement
Agency Agreement, D. Boral received a cash fee of 6.0% of the aggregate gross proceeds paid to the Company for the securities sold in
the Offering and reimbursement of certain out-of-pocket expenses of $50,000. The Placement Agency Agreement contains customary representations,
warranties and agreements of the parties, and customary indemnification obligations of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the Warrant,
Pre-Funded Warrant, Purchase Agreement, and Placement Agency Agreement, and Registration Rights Agreement, does not purport to be complete
and is subject to, and qualified in its entirety by reference to, the full text of the form of Warrant, form of Pre-Funded Warrant, form
of Purchase Agreement, Placement Agency Agreement and form of Registration Rights Agreement, copies of which are filed as Exhibits 4.1,
4.2, 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The representations, warranties
and covenants contained in the Purchase Agreement and the Placement Agency Agreement were made solely for the benefit of the parties to
such agreements and may be subject to limitations agreed upon by the contracting parties. Accordingly, such agreements are incorporated
herein by reference only to provide investors with information regarding the terms of such agreements, and not to provide investors with
any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company&#8217;s
periodic reports and other filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information contained
above in Item 1.01 related to the Pre-Funded Warrants and Warrants is hereby incorporated by reference into this Item 3.02. The Pre-Funded
Warrants, Warrants, Pre-Funded Warrant Shares and Warrant Shares are being sold and issued without registration under the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act
as a transaction not involving a public offering and Rule 506 promulgated under the Securities Act as sales to an accredited investor,
and in reliance on similar exemptions under applicable state laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company issued a press release
announcing the pricing of the Offering on February 18, 2026. The full text of the press release is attached hereto as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated by reference herein.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 92%; text-align: justify"><a href="ea027777101ex4-1_olbgroup.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027777101ex4-2_olbgroup.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027777101ex10-1_olbgroup.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement, dated February 18, 2026.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027777101ex10-2_olbgroup.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency Agreement, dated February 18, 2026, by and between The OLB Group, Inc. and D. Boral Capital LLC.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027777101ex10-3_olbgroup.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement, dated February 18, 2026.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea027777101ex99-1_olbgroup.htm">Press Release, dated February 18, 2026.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dated: February 23, 2026</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ronny Yakov</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronny Yakov</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6POZWRHSPjiniFBkivhaXSXFrRlp1fpJ/ad0QQyAk955cIUKxppVukOG8LAs4Yts1yiGUWCOjuaB3ZJttCn6WeNXWsTJuWH9gRp5Bz8yiqfL3wfnQFqsUYjlJFhM5g3iayjkcdiL46hmZWldonFYNKFPBgaljjU7xa/xwVD0Zal9D0gnZajIpJFE8ym+QcSJhTw/1JL5ZKIpMBOFQgVgz3TvvynuH5ktC3mDr4+xI/zv4ANDiSmU= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea027777101ex4-1_olbgroup.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 62pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
OLB GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Warrant Shares: </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 2.5in; text-align: right">Issue Date: February 19, 2026</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [___] or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled,
upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Effective
Date (the &ldquo;<U>Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York, New York time) on five year anniversary of the Effective
Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from The OLB Group, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to [___] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s Common Stock (as defined below). The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1 or in that
certain Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated as of February 18, 2026, among the Company
and the purchasers signatory thereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or other day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,
(b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions,
(c) following the one year anniversary of the Closing Date provided that a holder of Shares or Warrant Shares is not an Affiliate of the
Company, or (d) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the
Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified
opinion that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall
be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company required to be listed pursuant to Item 601(b)(21) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Transfer Online, Inc., the current transfer agent of the Company, with a mailing address of 317 SW Alder Street,
2nd Floor Portland, OR 97204 and a phone number of (503) 227-2950, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise of
Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as Exhibit A (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) first (1st) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The exercise price per share of Common Stock under this Warrant shall be $0.92, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
If at any time after the six month anniversary of the Issue Date, there is no effective registration statement registering or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(A)</TD><TD STYLE="text-align: justify">= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the
Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the
time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(X) = the number of Warrant Shares
that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a
cash exercise rather than a cashless exercise.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<U>VWAP</U>&rdquo; means, for
any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on
a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York,
New York time) to 4:02 p.m. (New York, New York time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties hereto acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares
being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section
2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery of
Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent
to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or book-entry statement,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days
comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
by the Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for
each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The
Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and
exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however, that the Holder shall
be required to return any Warrant Shares subject to any such rescinded exercise notice concurrently with the return to Holder of the aggregate
Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s right to acquire such Warrant Shares
pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto, duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Issuance Limitation</U>.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant. Notwithstanding the foregoing and for avoidance
of doubt, to comply with the rules of The Nasdaq Stock Market LLC, the Company shall not effect any exercise of this Warrant, and a Holder
shall not have the right to exercise any portion of this Warrant, to the to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise such Holder or any of its affiliates would beneficially own in excess of 19.99%
of the Common Stock or such lesser percentage required by The Nasdaq Stock Market LLC without first obtaining stockholder approval in
accordance with the listing rules of The Nasdaq Stock Market LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;<U>Section
3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental Transaction</U>.
If, at any time while the Warrants are outstanding: the Company, directly or indirectly, in one or more related transactions effects any
merger or consolidation of the Company with or into another person; the Company, directly or indirectly, effects any sale, lease, license,
assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions;
any direct or indirect purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant
to which holders of shares of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of 50% or more of the Company&rsquo;s shares of Common Stock or 50% or more of the total voting power
of the Company&rsquo;s shares of Common Stock; the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock
are effectively converted into or exchanged for other securities, cash or property; or the Company, directly or indirectly, in one or
more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off or scheme of arrangement) with another person or group of persons whereby such other person
or group acquires 50% or more of the Company&rsquo;s shares of Common Stock or 50% or more of the total voting power of the Company&rsquo;s
shares of Common Stock (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;); then, upon any subsequent exercise of a Warrant, the Holder
shall have the right to receive, for each share of Common Stock that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder, the number of shares of capital stock of the successor or
acquiring corporation or of the Company, if it is the surviving corporation, or depositary shares representing those shares, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation). For purposes of any
such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based
on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction and the Company
shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be
received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental
Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently
with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black
Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental
Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the
Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form
of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered
and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in
the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among
alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock
of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction)
in such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;Bloomberg&rdquo;) determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B) an expected volatility equal to 100%, (C) the underlying price per share used in such calculation shall
be the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier), (D) a remaining option time equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five
Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;),
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant
to written agreements in form reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to such Holder in exchange for this Warrant a security of the
Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant that is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the shares of Common Stock prior to such Fundamental Transaction and the value of such shares of capital
stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value this Warrant
had immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction, the
Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the date of such Fundamental
Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the
Successor Entity or Successor Entities, jointly and severally with the Company), and may exercise every right and power of the Company
prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this
Warrant with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named
as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding. For the avoidance of doubt, the Holder shall
be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares
of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets
of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E)
the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in
each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant
Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to receive the
cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle an exercise
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
(which means that no further sums are required to be paid by the holders thereof in connection with the issue thereof) and free from all
taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;Except and to
the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Non-waiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right to
exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver by the Holder of
any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission thereunder. Without
limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall
be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate
proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o) <U>Piggy Back
Registration Rights</U>. If, at any time while this Warrant is outstanding, there is not an effective registration statement covering
all of the Warrant Shares and the Company shall determine to prepare and file with the Commission a registration statement relating to
an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to the Holder a written notice of such determination and, if within
fifteen days after the date of the delivery of such notice, Holder shall so request in writing, the Company shall include in such registration
statement all or any part of such Warrant Shares that the Holder requests to be registered.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE TO COMMON STOCK PURCHASE WARRANT]&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><B>THE OLB GROUP, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Ronny Yakov</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">TO: <B>________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant dated February [_], 2026 (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744; in lawful money of the United States,
payable to the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#9744; if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrant Shares shall be delivered to the following DWAC Account
Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Name of Investing Entity:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><I>Signature of Authorized Signatory of Investing Entity</I>:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Authorized Signatory:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title of Authorized Signatory:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Signature:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea027777101ex4-2_olbgroup.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
OLB GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify">Warrant Shares: </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 26%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%; text-align: right">Initial Exercise Date: February 19, 2026</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PREFUNDED COMMON STOCK
PURCHASE WARRANT (&ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, ______________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Expiration
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from The OLB Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 2,857,142 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
dated as of February 18, 2026 (the &ldquo;<U>Purchase Agreement</U>&rdquo;), by and between the Company and the purchasers listed on the
signature page thereto. The following terms have the meanings indicated in this <U>Section 1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home,&rdquo; &ldquo;shelter-in-place,&rdquo; &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Transfer Online, Inc., the current transfer agent of the Company, with a mailing address of 317 SW Alder Street,
2<SUP>nd</SUP> Floor, Portland, OR 97204, and phone number of (503) 227-2950, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; shall have the meaning ascribed to such term in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise of
Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Expiration Date by delivery to the Company of a duly executed facsimile copy or PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice
of Exercise</U>&rdquo; and the date thereof, each an &ldquo;<U>Exercise Date</U>&rdquo;). Within the earlier of (i) one (1) Trading Day
and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in <U>Section 2(d)(i)</U> herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in <U>Section 2(c)</U> below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the
Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.000 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder
shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject
to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) the Bid Price of the Common Stock on the principal Trading Market (as defined in the Purchase Agreement)
as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within
two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this <U>Section 2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">i. <U>Delivery of
Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent
to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising
the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each Trading Day after
such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the Fast Automated Securities Transfer Program so long as this Warrant remains outstanding and
exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New
York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement,
the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date
and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, <I>provided</I> that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">ii. <U>Delivery of
New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon
surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the
rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U>
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of <U>Section
2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">vi. <U>Charges, Taxes
and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">vii. <U>Closing of Books</U>. The Company
will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <U>Section 2(e)</U>, beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this <U>Section 2(e)</U>, <U>provided</U> that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section
2(e)</U> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the
terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the
number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as
a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), occurs or is consummated,
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for
which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U>
on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company shall
cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this <U>Section 3(d)</U> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had
been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum
of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or
substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or
property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the
Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear
upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) Transfer Restrictions.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except as expressly
set forth in <U>Section 3</U>. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo;
and to receive the cash payments contemplated pursuant to <U>Sections 2(d)(i)</U> and <U>2(d)(iv)</U>, in no event will the Company be
required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request, or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder of this
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Signature Page Follows)</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">[SIGNATURE PAGE TO PREFUNDED
COMMON STOCK PURCHASE WARRANT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><B>THE OLB GROUP, INC.</B></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ronny Yakov</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>NOTICE OF EXERCISE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To: THE OLB GROUP, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) Payment shall take the
form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#9744; in lawful money of the United States;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> &#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) Accredited Investor. The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature of Authorized Signatory of Investing
Entity: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ASSIGNMENT FORM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply the required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Please Print)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Address:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Phone Number:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Email Address:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Dated: _______________ __, ______</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Holder&rsquo;s Signature:__________________________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Holder&rsquo;s Address:__________________________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea027777101ex10-1_olbgroup.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED FEBRUARY 18, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right; text-indent: -0.5in"><B>Exhibit
10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><B>SECURITIES
PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of February 18, 2026, between The OLB Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the of the
Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) contained in Section 4(a)(2) thereof and/or Regulation D
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1<SUP>st</SUP>)
Trading Day following the date hereof (or the second (2<SUP>nd</SUP>) Trading Day following the date hereof if this Agreement is signed
on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which warrants shall be exercisable commencing upon the Effective Date (as defined in the Common Warrant) of the
issuance date at an exercise price of $0.92 per share, subject to adjustment and will expire five (5) years from the Effective Date, in
the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock underlying the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, 11<SUP>th</SUP> Fl.,
New York, NY 10105.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period
in Section 4.11(a) herein, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $1.05, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means D. Boral Capital LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><U>&ldquo;Pre-Funded
Warrants</U>&rdquo; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and will expire when exercised in full, in the
form attached hereto as <U>Exhibit B.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><U>Registration Rights Agreement</U>&rdquo;
means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers, in the form of <U>Exhibit
C</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares, the Common Warrant Shares and Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means, collectively, the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, the Pre-Funded Warrants (if applicable) and
the Common Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next
to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (minus, if applicable, a
Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants
are exercised).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary as defined in Rule 405 under the Securities Act and listed in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Common Warrants, the Pre-Funded Warrants, the Registration Rights Agreement, the Placement
Agency Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the
transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Transfer Online, Inc., the current transfer agent of the Company, with a mailing address of 317 SW Alder Street,
2nd Floor Portland, OR 97204, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><U>&ldquo;Variable Rate Transaction</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock are then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock are not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported,
or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants and the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means, the Pre-Funded Warrant Shares and Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Closing. On the Closing Date,
upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement
by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate
of approximately $3,000,000 of Shares and Common Warrants, provided, however, that, to the extent that a Purchaser determines, in its
sole discretion, that such Purchaser&rsquo;s Subscription Amount (together with such Purchaser&rsquo;s Affiliates, and any Person acting
as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would cause such Purchaser&rsquo;s beneficial ownership
of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing
Shares, such Purchaser may elect, by so indicating such election prior to their issuance, to purchase Pre-Funded Warrants in lieu of Shares
in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;Beneficial Ownership
Limitation&rdquo; shall be 4.99% (or, at the election of the Purchaser, 9.99%) of the number of shares of Common Stock outstanding immediately
after giving effect to the issuance of the Securities on the Closing Date. In each case, the election to receive Pre-Funded Warrants is
solely at the option of the Purchaser. Each Purchaser shall deliver to the Company, via wire transfer or a certified check, immediately
available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser,
and the Company shall deliver to each Purchaser its respective Shares and a Warrant, as determined pursuant to Section 2.2(a), and the
Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the
covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing
documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.1 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) a
legal opinion of Company Counsel, substantially in the form acceptable to the Placement Agent and each of the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) a
Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 125% of such Purchaser&rsquo;s
Shares, with an exercise price equal to $0.92, subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) if
applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser
to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to
Pre-Funded Warrants (as elected by the Purchaser) divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal
to $0.0001 per share of Common Stock, subject to adjustment therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) such
Purchaser&rsquo;s Subscription Amount (less the aggregate exercise price of the Pre-Funded Warrants issuable to such Purchaser hereunder,
if applicable), which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.2 <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified
by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the SEC Reports, the Company hereby makes the following representations and
warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) <U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, or condition (financial or otherwise) of the Company and the Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and, to the knowledge
of the Company, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit
or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) application(s) to each applicable Trading Market for the listing of the Shares and Common Warrant
Shares for trading thereon in the time and manner required thereby, (iv) the filing with the Commission of the Registration Statement
and (v) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(f) <U>Issuance
of the Securities; Registration</U>. The issuances of the Securities are duly authorized by all necessary corporate actions on the part
of the Company. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, and free and clear of all Liens imposed by the Company. The Warrant Shares,
when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, and free and clear of
all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to this Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(g) <U>Capitalization</U>.
As of the date hereof, the authorized capital stock of the Company consists of 50,000,000 shares of Common Stock, $0.0001 par value per
share and 10,000 shares of Series A preferred stock, $0.01 par value per share. No Person has any right of first refusal, preemptive right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents, except as described
in SEC Reports. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to
purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or any of
its subsidiaries, except as described in the SEC Reports. All of the outstanding shares of capital stock of the Company are duly authorized,
validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws, and
none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the
Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital
stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(h) <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 12 months
preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
&ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not, and has not been
in the past two years, an issuer identified in Rule 144(i)(1)(i) and has filed with the Commission current &ldquo;Form 10 information&rdquo;
(as defined in Rule 144(i)(3)) at least 12 months prior to the date of this Agreement reflecting its status as an entity that is no longer
an issuer identified in Rule 144(i)(1)(i).The financial statements of the Company included in the SEC Reports comply in all material respects
with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time
of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied
on a consistent basis during the relevant periods (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could
reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not materially altered its method of accounting, and (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock. The Company does not have pending before the Commission any request for confidential treatment of information. .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(j) <U>Litigation</U>.
Except as set forth in the SEC Reports there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;), which (i) adversely affects or challenges the legality, validity or enforceability of
any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected
to result in a Material Adverse Effect. The Commission has not issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(k) <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. To the knowledge of the Company, no executive officer of the
Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal,
state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(l) <U>Compliance</U>.
The Company and its Subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure
to be so in compliance would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to
pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or
subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the
environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of
any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(o) <U>Title
to Assets</U>. Except as otherwise disclosed in SEC Reports, the Company and the Subsidiaries have good and marketable title in fee simple
to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business
of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value
of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease
by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of
such real property, improvements, equipment or personal property by the Company or such subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
described in the SEC Reports as being owned or licensed by them or which are necessary for the conduct of their respective businesses
as currently conducted or as currently proposed to be conducted and which the failure to so have could have a Material Adverse Effect
(collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Neither the Company nor any Subsidiary has received, since the
date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor
any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(r) <U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, to the knowledge of the Company, none of the officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance, in all material respects, with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(t) <U>Certain
Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(u) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(v) <U>[Reserved.]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(w) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. The Company is, to its knowledge, in compliance with all such listing and maintenance
requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established
clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(x) <U>[Reserved.]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(y) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby taken as a whole, is true and correct in all material respects and does not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under
which they were made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(z) <U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be
integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of any Trading Market on
which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(aa) <U>[Reserved.]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(bb) <U>Tax Status</U>. Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the
Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise
tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)
has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to
which such returns, reports or declarations apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(cc) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any such Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(dd) <U>Accountants</U>.
The Company&rsquo;s registered independent accounting firm is RBSM LLP, an independent registered public accounting firm. To the knowledge
and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ee)  <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the
capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company
further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective
representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental
to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision
to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ff) <U>Acknowledgment Regarding
Purchaser&rsquo;s Trading Activity</U><FONT STYLE="text-decoration: none">. Anything in this Agreement or elsewhere herein to the contrary
notwithstanding (except for Sections 3.2(f) and 4.11 hereof), it is understood and acknowledged by the Company that: (i) none of the
Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation,
Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may
negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. </FONT>The Company further understands and acknowledges that (y) one or more Purchasers
may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Common Warrant Shares deliverable with respect to Securities are being determined, and (z) such
hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time
that the hedging activities are being conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(gg) <U>Regulation M Compliance</U>.&nbsp;
The Company has not (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation
paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(hh) <U>Reserved.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ii) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with
the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(jj) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or Affiliate of the Company or any Subsidiary acting on behalf of the Company or such Subsidiary is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(kk) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(ll) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Warrants or the Warrant Shares by the Company to the Purchasers as contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(mm) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Warrant or Warrant Shares by any form
of general solicitation or general advertising. The Company has offered the Warrants and Warrant Shares for sale only to the Purchasers
and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(nn) <U>No Disqualification
Events</U>. With respect to the Warrant and Warrant Shares to be offered and sold hereunder in reliance on Rule 506 under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;Issuer Covered Person&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo;
disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;Disqualification Event&rdquo;), except for
a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer
Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations
under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(oo) <U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(pp) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to
any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification
Event relating to any Issuer Covered Person, in each case of which it is aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) <U>Understandings
or Arrangements</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not
with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with
applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7)
or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(e) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(f) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that the Company or any
other Person representing the Company first contacted the Purchaser regarding the material pricing terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(g) <U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.1 <U>Removal of Legends</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">(a) The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Security under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have
the rights and obligations of a Purchaser under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of the Securities may reasonably request in connection with a pledge or transfer of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while
a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities
Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), (iii)
if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), without the requirement
for the Company to be in compliance with the current public information required under Rule 144 as to such Shares and Warrant Shares and
without volume or manner-of-sale restrictions], or (iv) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised
at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such Shares or Warrant Shares
may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144 (assuming
cashless exercise of the Warrants), or if the Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company
to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant Shares or if such legend
is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission) then such Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective
Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by
a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as the case may be, issued with
a restrictive legend (such date, the &ldquo;Legend Removal Date&rdquo;), deliver or cause to be delivered to such Purchaser a certificate
representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or
give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities
subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s
prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued
with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are
submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing
to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date
until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock,
that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;)
over the product of (A) such number of Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal
Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of
the delivery by such Purchaser to the Company of the applicable Warrant Shares (as the case may be) and ending on the date of such delivery
and payment under this Section 4.1(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.2 <U>Furnishing
of Information; Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) Until
the earliest of the time that (i) no Purchaser owns Securities (ii) the Common Warrants have expired or (iii) the Pre-Funded Warrants
have been fully exercised, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is
not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;Public Information Failure&rdquo;) then, in addition to such Purchaser&rsquo;s other
available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any
such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate Subscription
Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30th) day (pro rated for
periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b)
such time that such public information is no longer required for the Purchasers to transfer the Shares and Warrant Shares pursuant to
Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;Public
Information Failure Payments.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar
month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure
giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments
in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months)
until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure,
and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by 10:30 a.m. on February 18, 2026, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the
Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other
in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any
press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which
consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the
Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities
law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or regulation, Trading Market or FINRA rules or regulations, in which case the Company shall provide the Purchasers with prior
notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.5 <U>[Intentionally
Omitted]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or
any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the
basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.7 <U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate and working capital
purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade
payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common Stock or Common
Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.8 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct), the Company will indemnify each Purchaser
Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged
untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment
or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in
the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue
statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser
Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or
any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in
writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to
the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment
thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (1) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not
be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement, Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.10 <U>Listing
of Common Stock</U>. (a) The Company hereby agrees to use its reasonable best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it
will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all
of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take
all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects
with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to
maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing
corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.11 <U>Subsequent
Equity Sales. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(a) From
the date hereof until forty five (45) days after the Effective Date, the Company shall not issue, enter into any agreement to issue or
announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(b) From
the date hereof until six (6) months following the Effective Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;Variable Rate Transaction&rdquo; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such
debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market&rdquo; facility&rdquo;, whereby the Company may issue
securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless
of whether such agreement is subsequently canceled, provided, however, that after forty five (45) days after the Effective Date, the entry
into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering shall not be deemed a Variable Rate Transaction.
Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in
addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(c) Notwithstanding
the foregoing, this Section 4.11 shall not apply in respect of (i) an Exempt Issuance or (ii) the filing of any registration statement
on Form S-8 or any successor form thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.12 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.13 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction.&nbsp; Notwithstanding the foregoing and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described
in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.14 <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the
Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.15 <U>Existing
Warrant Amendment</U>. Upon the consummation of this Offering, the exercise price of the 410,147 warrants issued to the Purchaser on August
23, 2021 and November 8, 2021 (the &ldquo;Existing Warrants&rdquo;) shall, on a one-time basis only, be reduced to $0.92 and the term
shall be extended to February 19, 2029.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded Warrants
based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived
provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group
of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of
any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the
future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or
waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit
or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.8 <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.10 <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, or by electronic signature such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo;
signature page or electronic signature were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.13 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.14 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.15 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.16 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Lucosky Brookman LLP (&ldquo;Placement Agent Counsel&rdquo;), with offices located at 101 Wood Avenue South, Woodbridge, NJ 08830. Placement
Agent Counsel does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all
Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other
Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not
between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.17 <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.18 <U>Saturdays, Sundays,
Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.19 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.20 <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line"><B>THE OLB GROUP, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; layout-grid-mode: line; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; layout-grid-mode: line; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line"> Name: Ronny Yakov</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; layout-grid-mode: line">Title: Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line"><U>Address for Notice</U>:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">Attention: [&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">E-Mail: [&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; layout-grid-mode: line">Phone: [&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%; layout-grid-mode: line">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="width: 45%; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">Ellenoff Grossman &amp; Schole LLP</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">[&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="layout-grid-mode: line"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">Attention: [&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="layout-grid-mode: line"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">Email: [&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="layout-grid-mode: line"></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>THE
OLB GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: __________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DWAC for Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-funded Warrants __________________ Beneficial Ownership Blocker
<FONT STYLE="font-family: Wingdings">o</FONT> 4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants __________________ Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">o</FONT>
4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">o</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company
to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing
shall occur on the first Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement
(but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument,
certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation
of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as
applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Common Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Pre-Funded Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registration Rights Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea027777101ex10-2_olbgroup.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED FEBRUARY 18, 2026, BY AND BETWEEN THE OLB GROUP, INC. AND D. BORAL CAPITAL LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February 18, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">D. Boral Capital LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">590 Madison Avenue, 39<SUP>th</SUP>&nbsp;Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the terms and conditions herein (this
&ldquo;Agreement&rdquo;) The OLB Group, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), hereby agrees to sell up to an aggregate
of (i)&nbsp;2,857,142 (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock, $0.0001 par value per share (the &ldquo;Common Stock&rdquo;)
or pre-funded warrants in lieu of Shares (the &ldquo;Pre-Funded Warrants&rdquo;) and (ii)&nbsp;common stock purchase warrants (the &ldquo;Common
Warrants&rdquo;) to purchase up to an aggregate of 3,571,428 shares of Common Stock (the &ldquo;Common Warrant Shares&rdquo;) directly
to various purchasers (each, a &ldquo;Purchaser&rdquo; and, collectively, the &ldquo;Purchasers&rdquo;) through D. Boral Capital LLC,
as Placement Agent (the &ldquo;Placement Agent&rdquo;). This Agreement and the documents executed and delivered by the Company and the
Purchasers in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the &ldquo;Purchase
Agreement&rdquo;), shall be collectively referred to herein as the &ldquo;Transaction Documents.&rdquo; The Shares and the Common Warrants
are collectively referred to as the &ldquo;Securities.&rdquo; The Placement Agent may retain other brokers or dealers to act as sub-agents
or selected-dealers on its behalf in connection with the Offering. The Common Stock, Pre-Funded Warrants and Common Warrants are being
offered by the Company to certain investors in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the
&ldquo;Securities Act&rdquo;) and/or Regulation D promulgated thereunder, with the terms of the offering to be subject to market conditions
and negotiations among the Company, the Placement Agent and the prospective investors (the &ldquo;Offering&rdquo;). Terms not defined
herein shall have the meaning ascribed to them in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.<U>Agreement to Act as Placement Agent</U>.
On the basis of the representations, warranties and agreements contained in, and subject to the terms and conditions of, this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company hereby
authorizes the Placement Agent to act as its exclusive agent to solicit offers for the purchase of all or part of the Securities from
the Company in connection with the proposed offering of the Securities (the &ldquo;Offering&rdquo;). Until the Closing Date (as defined
below) or earlier upon termination of this Agreement pursuant to Section&nbsp;7, the Company shall not, without the prior written consent
of the Placement Agent, solicit or accept offers to purchase the Securities otherwise than through the Placement Agent,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Company hereby
acknowledges that the Placement Agent has agreed, as agent of the Company, to use its reasonable &ldquo;best efforts&rdquo; to solicit
offers to purchase the Securities from the Company on the terms and subject to the conditions set forth herein. The Placement Agent shall
use commercially reasonable efforts to assist the Company in obtaining performance by each Purchaser whose offer to purchase Securities
has been solicited by the Placement Agent and accepted by the Company, but the Placement Agent shall not, except as otherwise provided
in this Agreement, be obligated to disclose the identity of any potential purchaser or have any liability to the Company in the event
any such purchase is not consummated for any reason. Under no circumstances will the Placement Agent be obligated to underwrite or purchase
any Securities for its own account and, in soliciting purchases of the Securities, the Placement Agent shall act solely as the Company&rsquo;s
agent and not as principal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Subject to the provisions
of this Section&nbsp;1, offers for the purchase of the Securities may be solicited by the Placement Agent as agent for the Company at
such times and in such amounts as the Placement Agent deems advisable. The Placement Agent shall communicate to the Company, orally or
in writing, each reasonable offer to purchase Securities received by it as agent of the Company. The Company shall have the sole right
to accept offers to purchase Securities and may reject any such offer, in whole or in part. The Placement Agent shall have the right,
in its discretion reasonably exercised, without notice to the Company, to reject any offer to purchase Securities received by it, in whole
or in part, and any such rejection shall not be deemed a breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;Each Share and accompanying
Common Warrant are being sold to the Purchasers at a price of $1.05. The purchases of Securities by the Purchasers shall be evidenced
by the execution of Purchase Agreement by each of the Purchasers and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;As compensation for
services rendered, on the Closing Date (as defined in Section&nbsp;4 hereof), the Company shall pay to the Placement Agent by wire transfer
of immediately available funds to an account designated by the Placement Agent, an aggregate amount equal to six percent (6.0%) of the
gross proceeds received by the Company (the &ldquo;Placement Fee&rdquo;) from the sale of the Securities on such Closing Date. The Placement
Agent may retain other brokers or dealers to act as sub-agents on its behalf in connection with the Offering, the fees of which shall
be paid out of the Placement Fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;No Securities which
the Company has agreed to sell pursuant to this Agreement and the Purchase Agreement shall be deemed to have been purchased and paid for,
or sold by the Company, until such Securities shall have been delivered to the Purchaser thereof against payment by such Purchaser. If
the Company shall default in its obligations to deliver Securities to a Purchaser whose offer it has accepted, the Company shall indemnify
and hold the Placement Agent harmless against any loss, claim, damage or expense arising from or as a result of such default by the Company
subject to and in accordance with the procedures set forth in Section&nbsp;5(c)&nbsp;herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;The time and date
of closing and delivery of the documents required to be delivered to the Placement Agent pursuant to Sections 3 and 4 hereof (the &ldquo;Closing&rdquo;)
shall be at 10:00 a.m.&nbsp;(Eastern Time) on February 19, 2026 (the &ldquo;Closing Date&rdquo;) at the office of Lucosky Brookman LLP,
101 Wood Avenue South, Woodbridge, NJ 08830, or at such other time and location as the Company and the Placement Agent shall otherwise
agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) The Placement Agent represents
and warrants that it: (i) is a member in good standing of FINRA, (ii) is registered as a broker/dealer under the Securities Exchange Act
of 1934, as amended, (iii) is licensed as a broker/dealer under the laws of the states applicable to the offers and sales of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&nbsp;<U>Representations and Warranties of the
Company</U>. The representations and warranties of the Company contained in Section&nbsp;3.1 and Article&nbsp;III of the Purchase Agreement
are hereby incorporated by reference in this Agreement, as if made directly by the Company to the Placement Agent on the date of this
Agreement, with the understanding that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;any defined terms
used in such incorporated sections shall have the meanings given to them in this Agreement or, if no definition is given to them in this
Agreement, such defined terms will have the meanings given to them in the incorporated sections;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;in the event of a
conflict in meaning or defined term between the incorporated sections and this Agreement, this Agreement shall control; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;references to &ldquo;this
Agreement&rdquo; in the incorporated sections from the Purchase Agreement means this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.&nbsp;<U>Conditions of the Obligations of the
Placement Agent and the Purchasers</U>. The respective obligations of the Placement Agent hereunder and the Purchasers under the Purchase
Agreement are subject to each of the following terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The representations
and warranties of the Company in the Purchase Agreement and incorporated by reference in this Agreement and in any certificates delivered
pursuant to Section&nbsp;3(c)&nbsp;shall be true and correct when made and on and as of the Closing Date as if made on such date. The
Company shall have performed all covenants and agreements and satisfied all the conditions contained in this Agreement and the Purchase
Agreement required to be performed or satisfied by it at or before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Placement Agent
shall have received on the Closing Date a certificate, addressed to the Placement Agent and dated the Closing Date, of the chief executive
or chief operating officer and the chief financial officer or chief accounting officer of the Company, in their capacity as such officers,
to the effect that: (i)&nbsp;the representations, warranties and agreements of the Company in the Purchase Agreement were true and correct
when made and are true and correct as of the Closing Date; (ii)&nbsp;the Company has performed all covenants and agreements and satisfied
all conditions contained herein and in the Purchase Agreement and (iii)&nbsp;there has not occurred any material adverse change in the
assets, properties, condition, financial or otherwise, or in the results of operations, or business affairs of the Company and its subsidiaries
considered as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The Company shall
have furnished or caused to be furnished to the Placement Agent such further certificates or documents as the Placement Agent shall have
reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.&nbsp;<U>Covenants and other Agreements of the
Company and the Placement Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company covenants
and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;The Company shall cooperate
with the Placement Agent and its counsel with the offering under the laws of such jurisdictions as the Placement Agent may designate and
shall maintain such qualifications in effect so long as required for the distribution of the Securities; provided, however, that the Company
shall not be required in connection therewith, as a condition thereof, to qualify as a foreign corporation or to execute a general consent
to service of process in any jurisdiction or subject itself to taxation as doing business in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;On or before completion
of this offering, the Company shall make all filings required under applicable securities laws and by The Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)&nbsp;Prior to the Closing
Date, the Company will issue no press release or other communications directly or indirectly and hold no press conference with respect
to the Company, the condition, financial or otherwise, or the earnings, business affairs or business prospects of any of them, or the
offering of the Securities without the prior written consent of the Placement Agent unless in the judgment of the Company and its counsel,
and after notification to the Placement Agent, such press release or communication is required by law, or Nasdaq (or other applicable
exchange) rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Company agrees
to pay, or reimburse if paid by the Placement Agent, whether or not the transactions contemplated hereby are consummated or this Agreement
is terminated, all costs and expenses incident to the offering of the Securities and the performance of the obligations of the Company
under this Agreement including those relating to: (i)&nbsp;the preparation, printing, reproduction filing and distribution of the resale
registration statement including all exhibits thereto, the resale registration statement, all amendments and supplements thereto and any
document incorporated by reference therein, and the printing, filing and distribution of this Agreement; (ii)&nbsp;the preparation and
delivery of certificates for the Securities to or as directed by the Placement Agent or the Purchasers; (iii)&nbsp;the registration or
qualification of the Securities for offer and sale under the securities or Blue Sky laws, including the reasonable fees and disbursements
of counsel for the Placement Agent in connection with such registration and qualification and the preparation, printing, distribution
and shipment of preliminary and supplementary Blue Sky memoranda; (iv)&nbsp;the furnishing (including costs of shipping and mailing) to
the Placement Agent of copies of the resale registration statement and all amendments or supplements to the resale registration statement,
and of the several documents required by this Section&nbsp;to be so furnished, as may be reasonably requested for use in connection with
the offering and sale of the Securities by the Placement Agent or by dealers to whom Securities may be sold; (v)&nbsp;the filing fees
of FINRA in connection with its review of the terms of the public offering and reasonable fees and disbursements of counsel for the Placement
Agent in connection with such review; (vi)&nbsp;inclusion of the Securities for listing on Nasdaq; and (vii)&nbsp;all transfer taxes,
if any, with respect to the sale and delivery of the Securities by the Company to the Purchasers. The Company will reimburse the Placement
Agent for all reasonable out-of-pocket costs and expenses, including its legal fees and disbursements, in connection with the purchase
and sale of the Securities contemplated hereby in an amount not to exceed $50,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The Company acknowledges
and agrees that the Placement Agent has acted and is acting solely in the capacity of a principal in an arm&rsquo;s length transaction
between the Company, on the one hand, and the Placement Agent, on the other hand, with respect to the offering of Securities contemplated
hereby (including in connection with determining the terms of the Offering) and not as a financial advisor, agent or fiduciary to the
Company or any other person. Additionally, the Company acknowledges and agrees that the Placement Agent has not and will not advise the
Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company has consulted
with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the
transactions contemplated hereby, and the Placement Agent shall have no responsibility or liability to the Company or any other person
with respect thereto, whether arising prior to or after the date hereof. Any review by the Placement Agent of the Company, the transactions
contemplated hereby or other matters relating to such transactions have been and will be performed solely for the benefit of the Placement
Agent and shall not be on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5.&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company agrees
to indemnify and hold harmless the Placement Agent, its officers and employees and each person, if any, who controls the Placement Agent
within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act against any and all losses, claims,
damages and liabilities, joint or several (including any reasonable investigation, legal and other expenses incurred in connection with,
and any amount paid in settlement of, any action, suit or proceeding or any claim asserted), to which they, or any of them, may become
subject under the Securities Act, the Exchange Act or other Federal or state law or regulation, at common law or otherwise, insofar as
such losses, claims, damages or liabilities arise out of or are based upon any untrue statement or alleged untrue statement of a material
fact contained in any Transaction Document or any &ldquo;issuer-information&rdquo; filed or required to be filed pursuant to Rule&nbsp;433(d)&nbsp;of
the Rules, any amendment thereof or supplement thereto, or in any Blue Sky application or other information or other documents executed
by the Company filed in any state or other jurisdiction to qualify any or all of the Securities under the securities laws thereof (any
such application, document or information being hereinafter referred to as a &ldquo;Blue Sky Application&rdquo;) or arise out of or are
based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading; provided, however, that such indemnity shall not inure
to the benefit of the Placement Agent (or any person controlling such Placement Agent) on account of any losses, claims, damages or liabilities
arising from the sale of the Securities to any person by or through the Placement Agent if such untrue statement or omission or alleged
untrue statement or omission was made in Transaction Document or such amendment or supplement thereto, or in any Blue Sky Application
in reliance upon and in conformity with information furnished in writing by the Agent specifically for use in the Transaction Documents
(the &ldquo;Agent Information&rdquo;). This indemnity agreement will be in addition to any liability which the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Placement Agent
agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of Section&nbsp;15
of the Securities Act or Section&nbsp;20 of the Exchange Act, each director of the Company, and each officer of the Company who signs
the Registration Statement, against any losses, claims, damages or liabilities (including any reasonable investigation, legal and other
expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to which
such party may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the
Transaction Documents or any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission was made in the Transaction Documents or any such amendment or supplement in reliance
upon and in conformity with the Agent Information; provided, however, that the obligation of the Placement Agent to indemnify the Company
(including any controlling person, director or officer thereof) shall be limited to the amount of the Placement Fee actually received
by the Placement Agent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Any party that proposes
to assert the right to be indemnified under this Section&nbsp;will, promptly after receipt of notice of commencement of any action, suit
or proceeding against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section,
notify each such indemnifying party of the commencement of such action, suit or proceeding, enclosing a copy of all papers served. No
indemnification provided for in Section&nbsp;5(a)&nbsp;or 5(b)&nbsp;shall be available to any party who shall fail to give notice as provided
in this Section&nbsp;5(c)&nbsp;if the party to whom notice was not given was unaware of the action, suit or proceeding to which such notice
would have related and was prejudiced by the failure to give such notice but the omission so to notify such indemnifying party of any
such action, suit or proceeding shall not relieve it from any liability that it may have to any indemnified party for contribution or
otherwise than under this Section&nbsp;5. In case any such action, suit or proceeding shall be brought against any indemnified party and
it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to
the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel
reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of its election
so to assume the defense thereof and the approval by the indemnified party of such counsel, the indemnifying party shall not be liable
to such indemnified party for any legal or other expenses, except as provided below and except for the reasonable costs of investigation
subsequently incurred by such indemnified party in connection with the defense thereof. The indemnified party shall have the right to
employ its counsel in any such action, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless
(i)&nbsp;the employment of counsel by such indemnified party has been authorized in writing by the indemnifying parties, (ii)&nbsp;the
indemnified party shall have been advised by counsel that there may be one or more legal defenses available to it which are different
from or in addition to those available to the indemnifying party (in which case the indemnifying parties shall not have the right to direct
the defense of such action on behalf of the indemnified party) or (iii)&nbsp;the indemnifying parties shall not have employed counsel
to assume the defense of such action within a reasonable time after notice of the commencement thereof, in each of which cases the fees
and expenses of counsel shall be at the expense of the indemnifying parties. An indemnifying party shall not be liable for any settlement
of any action, suit, and proceeding or claim effected without its written consent, which consent shall not be unreasonably withheld or
delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;No indemnifying party
shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment
in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named and indemnity
was or would be sought hereunder by such indemnified party, unless such settlement, compromise or consent (a)&nbsp;includes an unconditional
release of such indemnified party from all liability for claims that are the subject matter of such action, suit or proceeding and (b)&nbsp;does
not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6.&nbsp;<U>Contribution</U>. In order to provide
for just and equitable contribution in circumstances in which the indemnification provided for in Section&nbsp;5(a)&nbsp;or 5(b)&nbsp;is
due in accordance with its terms but for any reason is unavailable to or insufficient to hold harmless an indemnified party in respect
to any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate
losses, liabilities, claims, damages and expenses (including any investigation, legal and other expenses reasonably incurred in connection
with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted, but after deducting any contribution
received by any person entitled hereunder to contribution from any person who may be liable for contribution) incurred by such indemnified
party, as incurred, in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and
the Placement Agent on the other hand from the offering of the Securities pursuant to this Agreement or, if such allocation is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to above but also the relative
fault of the Company on the one hand and the Placement Agent on the other hand in connection with the statements or omissions which resulted
in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations. The Company and the
Placement Agent agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;6 were determined by pro rata
allocation or by any other method of allocation which does not take account of the equitable considerations referred to above. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any
litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based
upon any such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section&nbsp;6,
(i)&nbsp;the Placement Agent shall not be required to contribute any amount in excess of the Placement Fee actually received by the Placement
Agent; and no person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;6,
each person, if any, who controls an Placement Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of
the Exchange Act shall have the same rights to contribution as the Placement Agent, and each director of the Company, each officer of
the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of the Section&nbsp;15
of the Securities Act or Section&nbsp;20 of the Exchange Act, shall have the same rights to contribution as the Company. Any party entitled
to contribution will, promptly after receipt of notice of commencement of any action, suit or proceeding against such party in respect
of which a claim for contribution may be made against another party or parties under this Section&nbsp;6, notify such party or parties
from whom contribution may be sought, but the omission so to notify such party or parties from whom contribution may be sought shall not
relieve the party or parties from whom contribution may be sought from any other obligation it or they may have hereunder or otherwise
than under this Section&nbsp;6. No party shall be liable for contribution with respect to any action, suit, proceeding or claim settled
without its written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&nbsp;<U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;This Agreement may
be terminated by the Placement Agent, in the absolute discretion of the Placement Agent, by notifying the Company at any time at or before
the Closing Date if (i)&nbsp;trading in the Common Stock has been suspended by the Commission or The Nasdaq Stock Market, (ii)&nbsp;trading
in securities generally as reported by Bloomberg L.P. has been suspended or limited, or minimum prices have not been established on securities
whose trades are reported by such service, or on any trading market, (iii)&nbsp;a banking moratorium has been declared either by the United
States or New York State authorities, (iv)&nbsp;there has occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or (v)&nbsp;any material adverse change in, any financial market which,
in the case of clauses (i)&nbsp;through (v), in the reasonable judgment of the Placement Agent, makes it impracticable or inadvisable
to market the Securities or enforce contracts for the sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;If this Agreement
is terminated pursuant to any of its provisions, the Company shall not be under any liability to Placement Agent, and the Placement Agent
shall not be under any liability to the Company, except that if this Agreement is terminated by the Placement Agent because of any failure,
refusal or inability on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement or the
other Transaction Documents, the Company will reimburse the Placement Agent for all out-of-pocket expenses (including the reasonable fees
and disbursements of its counsel) incurred by it in connection with the proposed Offering or in contemplation of performing their obligations
hereunder, provided that such reimbursement shall not exceed $25,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8.&nbsp;<U>Miscellaneous</U>. The respective agreements,
representations, warranties, indemnities, rights of contribution and other statements of the Company, and the Placement Agent, as set
forth in this Agreement or made by or on behalf of them pursuant to this Agreement, shall remain in full force and effect, regardless
of any investigation (or any statement as to the results thereof) made by or on behalf of the Placement Agent or the Company or the or
any of their respective officers, directors or controlling persons referred to in Sections 5, 6 and 7 hereof, and shall survive delivery
of and payment for the Securities. In addition, the provisions of Sections 4(b), 5, 6 and 7 shall survive the termination or cancellation
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement has been and is made for the benefit
of the Placement Agent, the Company and their respective successors and assigns, and, to the extent expressed herein, for the benefit
of persons controlling the Placement Agent, or the Company, and directors and officers of the Company, and their respective successors
and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. The term &ldquo;successors and
assigns&rdquo; shall not include any Purchaser merely because of such purchase. The invalidity or unenforceability of any Section, paragraph
or provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If
any Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed
to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amendment or waiver of any provision of this
Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless and until the same shall be
in writing and signed by the Company and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All notices and communications hereunder shall
be in writing and mailed or delivered or by telephone or if subsequently confirmed in writing, or other electronic transmission (a)&nbsp;if
to the Placement Agent, c/o D. Boral Capital LLC, 590 Madison Avenue, 39<SUP>th</SUP>&nbsp;Floor, New York, New York 10022 Attention:
Equity Capital Markets, and to Lucosky Brookman LLP, 101 Wood Avenue South, Woodbridge, NJ 08830, Attention: Joseph Lucosky and (b)&nbsp;if
to the Company, to its agent for service as such agent&rsquo;s address appears on the cover page&nbsp;of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This Agreement and any claim, controversy or
dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New
York applicable to agreements made and to be performed in such state.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement may be signed in any number of
counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written
or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please confirm that the foregoing correctly sets
forth the agreement among us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OLB GROUP, INC.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Ronny Yakov</I></FONT></TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronny Yakov</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed: &nbsp; &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D. BORAL CAPITAL LLC</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Phil Wiederlight</I></FONT></TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phil Wiederlight</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ea027777101ex10-3_olbgroup.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, DATED FEBRUARY 18, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of February 18, 2026, between The OLB Group, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, by and between the Company and each Purchaser (the &ldquo;<U>Purchase
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in; text-align: justify">1.
<U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</B>
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 30th calendar day following
the Filing Date (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 60th calendar day following the Filing Date) and
with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 30th calendar
day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a &ldquo;full
review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following the date such additional Registration Statement is required
to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that one or more
of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date
as to such Registration Statement shall be the fifth (5<SUP>th</SUP>) Trading Day following the date on which the Company is so notified
if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading
Day, then the Effectiveness Date shall be the next succeeding Trading Day and the Company shall have ten additional Trading Days if required
to update for a quarterly filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, 15 calendar days following the Company&rsquo;s
filing of its Annual Report on Form 10-K and, with respect to any additional Registration Statements which may be required pursuant to
Section 2(c) or Section 3(c), the 30<SUP>th</SUP> calendar day following the date on which the Company is permitted by SEC Guidance to
file such additional Registration Statement related to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act, as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus
and Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon full
exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein),
(c) any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the Warrants (in each
case, without giving effect to any limitations on exercise set forth in the Warrants) and (d) any securities issued or then issuable upon
any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>,
that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness
of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect
to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities
have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been
previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise,
conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company), as reasonably determined by the Company, upon the advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">2. <U>Shelf
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities that are not then registered on an effective Registration Statement for a resale offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, including Form S-1, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed
by at least 85% in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U>
and substantially the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>,
that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent.
Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement
(including, without limitation, under Section 3(c)) to be declared effective by the Commission under the Securities Act as promptly as
possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to
keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered
by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale
restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed
and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically
request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately
notify the Holders via e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically
confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company
shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus
with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness
or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to
be registered for resale by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities
as a secondary offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and
subject to the provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior
to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration
of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation
612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify">First, the Company shall reduce or eliminate any securities
to be included other than Registrable Securities; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify">Second, the Company shall reduce Registrable Securities represented
by Warrant Shares (applied, in the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total
number of unregistered Warrant Shares held by such Holders).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the event of a cutback hereunder,
the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&rsquo;s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its
best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement
without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company subsequently
withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause as of the Filing Date
(i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance with
Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified
(orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo; or
will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective
amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within fifteen
(15) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order for such Registration
Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared
effective by the Commission by the Effectiveness Date of the Initial Registration Statement or (v) after the effective date of a Registration
Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included
in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be
consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five
(5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and
for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the
Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven (7) days
after the date payable, the Company will pay interest thereon at a rate of 10% per annum (or such lesser maximum amount that is permitted
to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts,
plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro
rata basis for any portion of a month prior to the cure of an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale
of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon
as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until
such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any
&ldquo;underwriter&rdquo; without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. <U>Registration
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the
filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to
be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register
for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account
the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration: none double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise
required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) Otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) The
Company shall, as applicable, use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the
registration of the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and the natural persons thereof that have voting and dispositive control over the shares. During any periods that
the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because
any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated damages that are
accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall
be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">4. <U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees
and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission,
(B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C)
in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation,
fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities),
(ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger,
telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the
Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation
of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred
in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall
the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction
Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">5. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a
result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons
with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each
of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent
role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the
fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without
limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, arising out of or
relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any
form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection
with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements
or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for
use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus
or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in
the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective
or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or
otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(c). The Company
shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions
contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such
Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party after having received prompt notification from the Indemnified
Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified
Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is
likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the
Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate
counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such
Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall,
without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified
Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that
are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that
the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by,
or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo;
or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">6. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security holders
(other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than
the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are registered
pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not prohibit
the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new securities are
registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of
such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company
that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that
any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the
Company and the Holders of 50.1% or more of the then outstanding Registrable Securities, provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a
waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each
Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities
shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof
with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect
the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent
relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in
accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of
the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective
rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to the Company&rsquo;s securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement
granting any registration rights with respect to any of the Company&rsquo;s securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com),
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <U>Piggy-Back
Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the
Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an
offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4
or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if within
fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in
such registration statement all or any part of such Registrable Securities such Holder requests to be registered; <U>provided</U>, <U>however</U>,
that the Company shall not be required to register any Registrable Securities pursuant to this Section 6 that are eligible for resale
pursuant to Rule 144 (without volume restrictions and provided the Company is in compliance with the current public information requirement
under Rule 144) promulgated by the Commission pursuant to the Securities Act or that are the subject of a then effective Registration
Statement that is available for resales or other dispositions by such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) <U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or
decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>THE OLB GROUP, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 35%">&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt"> Ronny Yakov</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt"> Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO REGISTRATION RIGHTS AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder</I>: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder (the
&ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell any or all of their securities covered hereby on the Nasdaq Capital Marketsor any other stock exchange, market or trading
facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder
may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the
block as principal to facilitate the transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">settlement of short sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a
stipulated price per security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a combination of any such methods of sale; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being offered
by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon
exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see &ldquo;Private
Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of common stock in order to permit the selling
shareholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants,
the selling shareholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and warrants, as of ________, 2026, assuming exercise of the warrants held by the selling shareholders on that
date, without regard to any limitations on exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo;
described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if
the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially
filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment
as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column
assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the warrants
and other warrants held by selling shareholders, a selling shareholder may not exercise any such warrants to the extent such exercise
would cause such selling shareholder, together with its affiliates and attribution parties, to beneficially own a number of shares of
common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following such exercise, excluding
for purposes of such determination shares of common stock issuable upon exercise of such warrants which have not been exercised. The number
of shares in the second and fourth columns do not reflect this limitation. The selling shareholders may sell all, some or none of their
shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 24%; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Selling Shareholder</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Number of shares of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of Common Stock Owned After Offering</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex C</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">THE
OLB GROUP, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Selling Stockholder Notice and Questionnaire</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of The OLB Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">QUESTIONNAIRE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Name.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Full Legal Name of Selling Stockholder</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                               </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities
are held:</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                   <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                   </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone
or with others has power to vote or dispose of the securities covered by this Questionnaire):</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                       <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                       </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>2. Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">Telephone:</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                 <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">E-Mail:</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">Contact Person:</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>3. Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: center">Yes &#9744; &#9;No &#9744;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for
investment banking services to the Company?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: center">Yes &#9744; &#9;No &#9744;</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&#9;Note:&#9;If &ldquo;no&rdquo;
to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: center">Yes &#9744; &#9;No &#9744;</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities
in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements
or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: center">Yes &#9744; &#9;No &#9744;</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Note:</TD><TD STYLE="text-align: justify">If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s
staff has indicated that you should be identified as an underwriter in the Registration Statement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Type and Amount of other securities beneficially owned by the Selling Stockholder:</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                           </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>5. Relationships with the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">State any exceptions here:</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus </FONT>and any amendments or supplements thereto<FONT STYLE="font-size: 10pt">.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of
the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Date: ____________________________</FONT></TD>
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Beneficial Owner:</FONT></TD>
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"> _________________________________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; width: 60%">_________________________________</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 35%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea027777101ex99-1_olbgroup.htm
<DESCRIPTION>PRESS RELEASE, DATED FEBRUARY 18, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OLB Group Inc. Announces Pricing of $3.0 Million
Private Placement at a Premium to Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEW YORK, NY / ACCESS Newswire / February 18, 2026 / </B>The OLB
Group, Inc. (NASDAQ:OLB) (&ldquo;OLB&rdquo; or the &ldquo;Company&rdquo;), a diversified fintech company providing payment processing and
digital asset technology solutions, today announced that it has entered into a securities purchase agreement with an institutional investor
for the purchase and sale of 2,857,142 shares of its common stock (or prefunded warrants in lieu thereof) together with warrants to purchase
up to 3,571,428 shares of common stock at combined purchase price of $1.05 per share and accompanying warrants. The warrants have an exercise
price of $0.92 per share, are exercisable directly after effectiveness of the resale registration statement for the common stock underlying
the warrants, and will have a term of five years from the effectiveness of the resale registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has also agreed to reduce the exercise price of certain
outstanding warrants held by the investor that were issued on August 23, 2021 and November 8, 2021 (the &ldquo;Existing Warrants&rdquo;)
to $0.92 per share and extend the term of the Existing Warrants three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The gross proceeds from the offering are expected to be approximately
$3.0 million, before deducting commissions and expenses of the offering. The closing of the offering is expected to occur on or about
February 19, 2026, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">D. Boral Capital LLC is acting as exclusive placement agent for the
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The offer and sale of the foregoing securities is made in a private
placement in reliance on an exemption from the registration requirement of the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), pursuant to Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, and applicable state securities
laws. Accordingly, the securities offered in the private placement may not be offered or sold in the United States except pursuant to
an effective registration statement or an applicable exemption from the registration requirement of the Securities Act and such applicable
state securities laws. Concurrently with the execution of the securities purchase agreement, the Company and the investors entered into
a registration rights agreement pursuant to which the Company has agreed to file a registration statement with the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) registering the common stock and shares of common stock underlying the warrants. Any offering of the
Company&rsquo;s securities under the resale registration statement will only be made by means of a prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing securities have not been registered under the Securities
Act, or applicable state securities laws. Accordingly, the common stock, warrants and underlying shares of common stock may not be reoffered
or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration
requirements of the Securities Act and such applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release does not constitute an offer to sell, or the solicitation
of an offer to buy any of the Company&rsquo;s securities, nor shall there be any offer, solicitation or sale of any of the Company&rsquo;s
securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of such state or jurisdiction.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About The OLB Group, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The OLB Group, Inc. (NASDAQ: OLB) is a diversified fintech company
providing innovative payment processing solutions, digital asset technology, and omnichannel commerce platforms. Through its SecurePay
payment gateway and complementary services, OLB enables businesses to accept and process payments seamlessly across multiple channels
while leveraging emerging technologies in digital assets and AI-driven commerce solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are subject to the &ldquo;safe
harbor&rdquo; created by those sections for such statements. All statements other than statements of historical fact are forward-looking
statements, including statements regarding the completion, size and timing of the offering. These forward-looking statements are often
indicated by terms such as &ldquo;aim,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;goal,&rdquo; &ldquo;intend,&rdquo; &ldquo;likely,&rdquo; &ldquo;look forward to,&rdquo; &ldquo;may,&rdquo; &ldquo;objective,&rdquo; &ldquo;plan,&rdquo;
&ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;slate,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo;
&ldquo;would&rdquo; and similar expressions and variations thereof. Forward-looking statements are based on management&rsquo;s beliefs and
assumptions and on information available to management only as of the date of this press release. OLB&rsquo;s actual results could differ
materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties
and other factors described under the heading &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K filed with the Securities and
Exchange Commission on April 15, 2025, as amended on April 29, 2025, and in our subsequent filings with the SEC. Given these risks, uncertainties
and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The OLB Group, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: ir@olb.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phone: (212) 278-0900 EXT 333</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>olb-20260218.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a05s7xRiXgen8uMYHRcOauECaP9xJBzKYlBsG10Hdl67ygmHTOJRy55FAsGYYsA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:OLB="http://olb.com/20260218" elementFormDefault="qualified" targetNamespace="http://olb.com/20260218">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://olb.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="olb-20260218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="olb-20260218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>olb-20260218_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>olb-20260218_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="olb-20260218.xsd#Cover" roleURI="http://olb.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://olb.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 18, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 18,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE OLB GROUP, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001314196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">12-4188568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1120 Avenue of the Americas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">278-0900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OLB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0277771-8k_olbgroup.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://olb.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0277771-8k_olbgroup.htm">ea0277771-8k_olbgroup.htm</File>
    <File>olb-20260218.xsd</File>
    <File>olb-20260218_lab.xml</File>
    <File>olb-20260218_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0277771-8k_olbgroup.htm": {
   "nsprefix": "OLB",
   "nsuri": "http://olb.com/20260218",
   "dts": {
    "inline": {
     "local": [
      "ea0277771-8k_olbgroup.htm"
     ]
    },
    "schema": {
     "local": [
      "olb-20260218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "olb-20260218_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "olb-20260218_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://olb.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-02-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277771-8k_olbgroup.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-02-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277771-8k_olbgroup.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://olb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-26-019383-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-019383-xbrl.zip
M4$L#!!0    (  R(5UP\] ODJ1H  )F1   9    96$P,C<W-S<Q+3AK7V]L
M8F=R;W5P+FAT;>T]:UO:RM;?\ROFY9R>K<_A$@(HJ/4\B-)BK5K1WK[X#,D
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MI\><WRX%J $ 5P=+[^AK0;?(EPL<@>BT,K[PR\4A#K.&11#:.\NXXU<7R$>
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M52'5,JX)*W#T]"E';^=@,]W!^1R/0K G^I,UCT!2EOCB8%##H98P=RX)'3Q
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M7Z#O865DC<ZJ]-$K3*0L/A+. D;SHR7]\(]"MDC)W59DBQ^^0Q?T@URR%=4
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M0?7D)"PMF:7CD2?RTT(3)K=#?<)%8;.RJIB"J7]W3 \^BPG^',;@%]FP>('
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MMX"1[VS/*:'%<#,%YDH)K[8W&EJ;3?']<+25\K<OZM!M^-&RD =M['B79&B
MJ.T">&-R^%).:[*E6"-"<B,L<PR3+#QB,J!67#@NXU+:Z_!?CL^XAU:"T)A!
M^0-V9T#B$@J:[&,F@]MIB;B" 1"[7A"]+7)0T]JWCG@T-U5%E"-Z24*PZC8C
MAK3&6"7,.9$L%E7*O)E/CKZ,+GZ.CHEN\**!56[B\>@Q[(17>0D+?P9*/8>-
M <+C//KZR\>'3ST%IY,;VQ__/QGA(*OXCZ3*R"<\1^?.R(=/$EDG"H\]&B<X
M-/_XN56U+D&/I>BT!=$,BDV%9(<ISBH9N9)4XAK3CDTPSY--G0IS"WGT:?T-
M,5)E/95<Z%HWZ'VS84!9+K$, L9NJY\7"=*EW)0YB-?H-D6ICA5'V!/OJA40
M")[E")X([:(\YT6*L9I&B.'Q6?CUE%C*F^NT;4@.6S>M5S$V3H+T46C=\^0]
M!\& A$97T>N#LX-H,J, 3YN@G'. 7W_SY' \2@;YSV'+/_WF\/$P0_J4&:I@
M[EO&2X=VW4[QP.0Z#J7?.[OXMJWQ)'40_T%.I*$- ^.F<%G/5+?,R?8S,!RU
MY"U2.\*=_E5T*R8-.\ZRXGWT%GT(V0ED_8%0<BU+KD <_>JPX%*B1C*>WQRC
MN*#_EYO"ES;R4_!;'M24YW]54OGVG*J"LH5L:F03U<%BA#&J2S=,3A!/%E,J
M,0$Q*?S.L+?$%EHF6246N[!#$TU:<$-R9>U!Y\+ =)V2'"&"J22KB88,[6:>
M'FI;"+<''3F[XT!F"",R7%08#93B]9Z6&S3SEG^,4TA)71:P+;"EX3Q=-YKB
M"%0TO6(J6:?T XRX3IG;2JBL@\"?3XSONRBU-$-/D=26E&M?>%NS@'M6U'MG
M>3P:*!D:FEV+N>M%X_U1?5F'6V?^H4U9MW3LW"$(_6P?A)8@]+.'%H3>>1M]
M-FUG;=]9W^#^S<OHXOCUR;^WM>L?(C$_XLE2+GL 'GM0/DODYX9C59I38F F
M;$C>VX5<*1Q#\!M<JE$ C<%(C 8M.=-TZJZ;-1V/Q)"0WE.1=IX*T/-X-84&
ML<FW!\E8-/V6EM[<F=DT](ZCS5IH(%U"E P=HO_\D*TXT?JW)_'AX2'^/S5+
M'U(;M>?[C"-I.QA'W(54)C-%(E/IVY 83(DS%;D<(,-<:8V,W8L,7/*4"R8]
MAV@WG]O73FO2E%=<&<E$J_V_=,U4:Q].T<:E\X8BV51R>565-%G#MXRT >'R
M_F=-I<_&'%W<H<MG:9$N,^KX5]X*;8;C6!V \!!;+/H)=-%S?X>W>H?HM2E"
M+2L'R_3OL=+6EM0-8WY=$MERADY2NL$GROZAR5&$0L\]R+ GEN:Z)%80 9S0
MI?2E$.<R&2D\,:L<^W1L-VJO<6@&Q(.@4#_=' 1(D5;<K*/>Y(VFQPB:ZG/_
M[O;L%<U2<I_$JF^]4.@E') G)T98WRR/1WZ:0U ^. Y/#[[^^C_1[8NUJM_-
MAN(//$SD:[Q8FT98!N,!6F[C\QBT!.QBPO->983:%4BNO)1E_&[Y4657;%)'
M;M-C+AB_[X_2OV9RL/,[?7.A^VZ_]T%T$L+.>/)<U[N6SW:3)6'/3.;UGB-A
M-<%;YM<IM:4)9J0%("&Z(A?[VTW()%8M]"-D)*;OHO6=O14S=9&5])VW;8'P
MT/V'U5]+*P\CDQ.=[+CE@_<WH42B"*=(L+."K]-*MRX +AU)PHSZEP;%0^;V
M^@.:YI#"XB!ZA]J7&Q,F=ON/1UA85#@7L%<'^^?4]""\\/'!DSC8KSSH)GF?
M1M18%CO4EJ349G>V*ZO?-DO[^_%(<R_)IR6V^\QM)WSNXX,CK,5[R>LGR.D_
MV?/^[M7;-Y?Z8+I@D<Z%7>H;I.9/_7SAI7\RS0C&JM\6%$^S6BXT0K><>Z3/
M(@.!48$!.TSK= [1^@0A]6\^[70<_>E1DX\; 3=I117DP8K48<**9K,:?^I@
M/X?I@OE*QJ,<C"6P0-=9(1):-ZNTX6F[0;:>MQMF;6]0IVG:%D"]GWYN!>RT
MLC-$R-+A/GBL &,T/719\K0!I8^@6XE@MS;W=98NHQ/V2\%V>,OM6E#8\%>O
M,M"\;,WR5P]^(6ZF$9AH8(:L'2 G S__IN1VT78E=)L[I #O<G>)%%ZWOO;]
MG&DEJ0_<&@Q56C9PM- W56-V3DYZ2DR8U(DN,4Z!&(*_Q9)E<DVW31S!I_LY
M\WO&4E>>4O&QG'7&A[?]7G0O>SV<]F7R,L[_L/[(T!OPBSH<"WGIUVE.::27
MYQ?1K"S?/X*YK>Y8$LEKM29>"HOD?:)[7H?S/VZTSI_S>27P;M2<+>')G15X
MX$=IETC[%_M(NT3:OWAHD?:_Y)Z>W)"5U$JA[2I4@BB71&/O#_(X^7[T^-E_
M#DM)'YUCV%FGO:B[#S49':)H;CC<_2U*RX<MOR8W&8))0-D8@ FB/UK>&*Q(
M7_2K/P1SA,J])S^[ZQ:B.JO?L8<HZX#8D3[EO#WXY68![H-=-7H*U$ M*\"C
M30PSW=7FB*BR2WN0;]_--!N=;N7MM[]GJ_^; SV?"Z@ \5WWQRNVQ@6WA2RZ
M*)M]8&+WP$3+D-P+8XI/<!_$'1.".4*MP[+;G<L_@Y+XE@[W'3;!(PH*<N,V
M9FR58(\_GWB \R)9I)>:&_Y'"EJB5A)!ESP"KS[GK>&2R^KQEYP06*34+^03
MDJOL++W^O,#L1\2S'V,\VT7V7[BDPCZP_5L"VY<8F2IGN; 6=SK\^CKS_O(4
MIU4(?QJ"+@P(W*=^.#V[2IN]MN"P8()]2Y+YG0)U5]+[1C.#-:>80^Q%E:[A
M:\UH44F1T,]K2U:THH03X,[=DYI?5)&VUXG"9D8Q18)P#/KH:5_F6+=(>PQ4
M.>\'T8D$4^U20EE,ML^BR:8@89X(*EAX#.;C$8'&Q8SS[5,Q4XV?WGE)S+/7
MI'_4[!&BQTQ?''6FB$?OL.[3!QX=XH1#G@=B)8["7+"I?X.Y:]FBPF>Y4!J-
MM,+8'Y8=--$VH];R)5*':??+;RDW_^#7146. [!A^KSC\U+L=BL< #V,/["S
MTI_E;>UN)^T0 /UR'P"5 .B7#RT ^I>+%I 1:(!(/?:@4>-[D_!AFX3$CL0>
M<+'X_0:B>AK;K4/,W*IY&'V\=;BWT7ZOC6:7Z@\PT![\>O399D%T:"?#+.DQ
MS![\W-Y,65@$C &T_XIR2/"Q-A.AUPI[1["AYZG4GKM&"?M8+B51L4R=:W[-
MW Q )J4P.W.]#7U>R_->^M6J-_6:Z;&[/-:^=MMBK*A O9<!BM#2!&O!!<72
M^*W@3C_2VJ/JK])"BW2V5O33NXQ'0R\##Y46J%3)L<J*;+59:55ZWT2D-8+Q
MLOJ:>0+,D&ZOD:X;ARLZWPZ+H^Q@P]T0 @B[HA;T^NVI*4I-""71+"G>DWF&
M<<RRRF!D?B"+=)XGJ C2C%#DLBXA^2/<S% HD3;>-->E$@S[A]$AY;M3,U^\
M,0[/F3_EIB&W@ BFZGDB'*JPO^"U&^P=F_'S&-/.+86Y@2T5F;L/\*<KZ00K
MI297,.;-@HFF, POM15:7F.'D8BD$*Y6+"'#[Y<.<2=5]6264,#(U%G(9G=@
MHQ2.U.)J)30OG9*"5?(>7BEKHFRUKA!>SXE:>B,8AS1[M*GC5NE'"ZW_9U0T
M?B[UE+:@\OSD[/SDXN3-Y?'EZ=LW%U17^?/Q^?GQF\O3DXM]ZJ5GB$^XE. \
MM.JYZN7G(;.>LC+(:YRN6V4V7:[#$$2/PH#\E/=,!&%\QQ['8CPRGD4'6/_I
M',O_20N*UJ+EMM3JD/'H& E#>!T78.@+2246_]$?]A=MWX"<_BV+S#5WSJJ]
M1;^#;YMS"K30O["@RH]C+J1^W O<=_0&3X1H1)A#Q(>3/6,GF"0I^ZKS/$TJ
M[?[].DN+/XP=X3,,6F*@!U;[K>&EX;/[WQP6F"=*L!4N41O:'RQ^1EU54VZK
M3F"'=B-X7X(JC#AHYMS $Q>$C,AJJ<XM/'6,JWSTE*EY<NMVVB^@VNI%YG#(
M&561F@[U]%CSFK$/39'G6F=8-5K>2L&-6B-W!'^"'4F?(OH%[[RNRG7*Q=QT
M<5VG2FE2PJ:L*J(<Q2MGFQIKGRE@(17D7$Z^V"!PZ@ 6E*TD>UP*,2[,=LWP
M=<:CFZP4^P:O6:3+!$M@9?/*5%"E=JUQNE8YH4&:DPD#?\US/K#!=&%M+\^O
M'BH[>8C%0CC0-?S>LAA*:6?[]$L!4WN3T-;P\2><.IX7,VNX ^KN)J"Z;8P"
MPP;'DL)PF5D(\/Y30RO8()DEZ)*"3AFT>[1;(VG^BPM.LHGM9K"^6 N1=?8O
M>US ?$V1LP_6+::2[36:?2F31B$'$G62Y#!)79H9($D7OBDSS).HJ[4A$,9D
ML,+<V?_4X<?Q'U'/[S7A\@@QY^JDOXDPF)AT;59GUO*QPJ(@RFK2B9188(K-
M,.=I,LMRL9'%25 6ODA).N.((TF=YXQ'X8-X8+3W<'8UX,2G*78K0;:VBPQ'
M$V]26TDRW677Q50O6DC=/_A%.;L\'&JY=V;:Q3HZ&6AI<]"*@K/6+=!@ 3&W
MH4>)"X1E'\R$8(/JPMP_,*O11(XXK*',L X<0::>-&@@=F'(@Z;LYHI3^[XH
M;_-T<94Z_@$'Y"O*R/?.AJU6LX.'%2_@%PFQEY!4MDX8EM"\I_U+;BQ1K54H
M 1NAQT0'+TW?"^<979[*Q2Q;^%*^=9]<)CXW<^H>D-;>)=7XU3[5**G&K_:I
MQL]L_R)O(TBJ8S[+;%)\.QZ=L(K1IJ>AQ7DM>M ;:\ZD'##;(MI8Z 64SC0#
M.;M9K213% V2* ME3Z?WB35YV<KH$]5LMG@;U]N$FX;L,2OU3<^6(NAXQ0G8
M74F&/FIXK2R":DHW.W@UFSA*VK"=;GIVYP<_N[.A0+3P9$U^%;)(#%RJ>10I
M-P3K5R1(ZE/CH(>6H ZNJ190++C:)YS"U^& P?,RJ19XKY?D."+M>G\TF'U'
ML 06F,8.D]?X/N0E\$_U#QY(<TV\E[W);FWA&KD.KKB< ^LUN%"X<=A,S:@Y
M04(3=.<5\:2LA.?*;8S;S.8RIEN+X-D,H,RM!_.C1I_#T5I0E:9[(R;1DL"]
M6VSL!$U/Q*W#-@&'^<ERI.MF&5OL?L^W5]A9ED@C<I6@=1%\WS,B/$0T(F=?
MDV5;:\R<*$8E$L_1 +J[Q/VU[9RI<<& =K59-W/"\H%FNT%B5BR(#7U&$_!V
M9]SYH?I N2^?6C*^R)M-O7C#J^<55@'#QI2=&%5,/>\2"&I'V[?B9U4I.H%L
M.1'FG4'GSC)W.7&Q2IET*2M^(5;9&\)UY%@/'D9,:":P9?1"'5NVBW%"E@G1
M2:$87Q7.YE(*EZ;*9ANA?'+.IW0O-8,W$P[O\8 ,-J3<!87WIB1L^A(F@:E3
M6<4Y&1_[<XP3:U:O-_';D2?WR7TC3\8C+U#BL#*;F/*PVW>7,NI>33&L4OL4
MQ:+D!!AA0#+):.%)GLLD12I].>Z1DK/AMEA+D#B)WHF>N&^&HQ^8XOF(\$?4
M%_U05[(U?O5?14!B2QJ)VW!OD"B]<<QY>#W-"56LH&A9U[P0F(RD5GXP(4PP
M-TOGY<K<;LH>9-PB1@,YX\2NAC@C4AIAS$@#6L0;AQYXVQ_LSBN]V16&E6!G
MT31Q#QB19/ASHJB2*:4.H-(SHVBR1XLLWVC,1AFR?<$>1@+F\S27P  [A;A!
M<XF 371SX'_1M.)IB_LG#>,#G))+?.L.EL'1,IEG'/%8I+/&KSE3.[#W[5D9
M$'5DIL0$Z8)?2U!"[T5KX^)7[B1NG5^K]$M*I$J?.CX%%)'BGL^X8&V]VGN[
M6;DI*-#$BDG2RRSG6["\KA$3=P^FVVLX*SXZ*7L-CE!,?5YCT^,5GTC[5'.<
M7C6Q")QC:-Y-'$;P*Q_89538IJ*)OBI!6!9$XI5[VY^B7OW3VYH-?>,)=\[$
ME5FF"U;B!07A$)_DY1^)A%;'VFG\&]?FOI7Y5FT;/<@)[VJU\K6) EL)JJV%
MKA'#S1HD'(^V1PE#,L5D"/WR@/3U+@&6K_<!%@FP?+T/L'QF^W>2DKWYBD*M
M=4Q69^TB$TZ>=Z,LTO##8CG+&2)P1>[27<#G2YC0*+$1',ZP+:A>)&:S@)-9
M9,PT)7>?P*2)(&,T#ES9!EQL,052GO6 ".:8I7),38Y]"F! %?COA?@W<-C'
MHRZ9\T?:X&F_J1W+4S%(P&D72OWP>OCI5=8(TEB^$]'3KGVOSJ!W+2?UU&$:
MC&/5:D6C_4MRSJDZFWZ(Z5EY18(F*>SK%ZJ(R*S"GPH7K]\M;-?C6&_L&P=E
MS0Z<MQ0KPRP^(<&8,YL4V@U7@;N)2Q2_%D"-"78N,30_$?W*>]+M3N%3)UV+
MQV9-'I#^FRQ)?IR*2^@\ >\*?ALLG!<DZD76?=XC+-V]$4$?U54OT@0'VRX)
M/U,W<\_M?80+!\8?^!;< [&N\#3U'&Z4&UQ+P,^#>RIX@1\31\L-0D"Y?S1%
M, NT ^M:&E?#1ST %+@G 5 0UU?6G7@=OVW8R0/'8EYO:_1.YLYTO9:W^ 2#
M9UC._:.WX7R$:U4WV) )NU@1S4%K^4)\#]YLE7P@(.PP!PY(,&DD*J0.EIIG
M(&CRZ;O/?/Y'_(J.N+1%%16N2"^W5PQ<6[K:#RU.MW"GS@1Z]>S0-1GH)RR*
M/:L/;";N.[7&&#L3_. J';5_?T'$Q=$Q=@U;I@0+KOV]6G?BWQU$8*^*'7"=
MF% %WH\[U<&]-C4:&6O<(FN"S- E<,[<I=3' ?'CGFB?\/\<P>#+$!+@+DN=
MYAR,CED.PZXQD3JHY"*51H:$26Y#Z'"RJ/>972<T@0QS/+.RX^DWO1W"EX6/
M? @GF!CCEO,%B([R/2=*A[TC=-*LL?H7WO<&8TS,JXF6I>\(K/AEX6Q1 A4Q
M!+=M-->9 2:DJ7W+;4)[],Q;+_K00!OM5/G=MG4(/8H'MLO'"56?,_.2? [W
MSS,OR0E[[W73O9&*F#&P""MU,/*>U[M-:O/03@RGLSELN,[M IIXFF'2K B9
M4NRY'Q6(EC<NE<>=2&YX3[4<"7ZRR<QM2^I)X-%F!-7J'8II@X[P@PH/3I .
M]-5N<713D@%M"^#T++C@I?]N2Z60CT;SI@(QI_T]ND&K( +8Q>RTMF(,6ZBY
MQ5V$<PKR]<H&>;=E/A^2YKMFA//)B_%(),"WAAG9^2 ][C%J#?!%T(ZDZE=!
MJ+N&S\08B%G)VMW$Y E]L^?0@1F/^)XM_](#78T-?3SW5HOV',</,8:J(<P^
M+L*C)U0&6$5'SS 9Y;*W>E*.'D>P79IKJH[2-IPM"X#R%21%ZNN24A^@6K-R
MH1!%'?AM$B;G01:)FR\Q4QP8OK*6V7"X<1I-R&74?NA8Y\+?U/;MV%N7=MN-
MZ:KMIS> &\^P-!4LA%3*\[B]$Y>76V<P<G8$W$_*B/G%QB/O(AJU$2#JNO@^
M>&,V<JEE"G;OX*0X56:K!\RMB#/F?A1GF9J%^XVF\#J[7\.RM/3#.JM"R4EM
M>/1!H-_4H,LJ"P9><&^DECH4O2/>1%^EN8F;R#H'%<$[;==6*U=1B3[I:"M
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MM)8)4E[U!E9(X?ZZI"52E]P;P&RN<1E3<O"E&,!AXM0/<!>W\(TN%] -=1B
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MTC1X2\,/7AIT56@U"D;5T^]4J43$68TZ7FRRF^SZ(*C+L)VU.H^9GC$FE"U
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MR>Q.,(^F^N3W4&Z9C!#M%^V6(MP#J$D=-]' LHU'@^L6F67C)W/6QGB*$K;
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MD58ZM9Y*[GWB6RIT?M$9IFOMN_M3V_>($;*5M#'F$6*[J>T.-3]!@@S<#YQ
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M(D;=&3-;N,>*^Z;<_ UWOMC<A5U_BO2J;*A$Q+CIPL?F@/463^?Q_N/1X_[
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M+/^_8E &R)^"RY RZ1'DHXC:#"^H%B"#I_8N:P!3^ZJ'@C.39W V!C/V;2-
M&[-[^Q 'HE:C2?2CG91BG6?0W]+;D&Q]DULY<0DFXZO6RL.Y). .!SX(%L1"
M-:I*+3KF'XQ'^&!'&T0X/3).@\A\$M'Y5>^/K@I;/-%'(/OYQ=EOOKTNR?Z#
M9]9M/V%B,L9(1*-%1SK31\\&V+WPK?6BQX=]-1Q3CP(V]OC0=*N=WIEVLCS]
MS'^:Z8X^?K;!/QF:;K<@,LL4^5_+R":X% CVT@+D=]_[Z3_#[ WN?@==ADE9
M48R "_A-LC8OZYJB#."Y$ *8?3*?IXTQHIZM\+\E%?@AXAZO$5P<?EZ+ZVB*
MI'TY)3SDE\WB2HHE&4-<.[">U_QTITW58)Y,;VAH;A,0IE61WM5BJ$1+/3)\
M.;IU1*"LIH++2[<V)\T.%0C7&P43$4RSU0>3M@C8]8DV4Z'T#9(D5)QQ75K4
M0*N]6FQZJ\7&P2XKG^T.NQ6[4J=V S<:1V8SQ_U9'S2-9CQ"^4Z9IQ$1<85^
M6MN)/&.&9LV1@16;( RFY9.O)&2550C.<(ZQ=;F16!)G&JT\ 36%UB6)"V$"
M;/<LZEN?_BQK3Y"1&][N%&6,)HJ](C[JN4*JP61!&"NSJA V(O'!3K_8?<,<
MZL^' 4W?6X\\9=T!'APWN(P!)H(^"8I=.^+6[V@*R[@X) N88%'XYLYVKGOJ
M[L^4*)K;82$$N;\;EMX-H\#(9S!T*\E^(X=(QC)4F1LQSYLR]H&CD:9+\;)*
M-HLXNJI 0"$T$@02&6@E5X,O-WD$GKX\>[I5<8?Z>CR2'286 <*%$8$L(1*?
M5)S=M:(IL8I/?YYZ1*F3ETY !J*5I97GH8A]Z,[">.^3?-.6P"5*-<::8[M>
MYF;$F\)"MN58QE("Y'"U41[[E!K RT<FK[^TAP%=U+!3I)"1]U&\Q@*,<.7S
MLEVH51<6@0;?B BBIIE.ZM4;F'_ABY6PMK]TC:CE%7NT_EXLN[:^/TD2C1+Y
MMS>?V9<>C^BM6\6N])8+'A47U!0I$J$DW$6, "WDV.ILU.[:B<CRN4&CA'/1
M?6U4J!S*S D^KG4*605B@_N=J63A1$I#C '(QXLZ9LHLCUF=IPDCQP61$* !
M0(SC?&&OO-;G/A;,&P2%BGLO1/)X^A1X(@M2D:HD3_L#@;W"8LEEZKR[3"<S
M>[P[@D:.M-(9YK3)-.K#A =:G1:(/[OZ_L,VZ*^?,*)MF+I\ (O-4%8ZC8HH
MB1 DP4/DM1ML/G"ZM'K=11UG5;G![6"E46=20C Y;P^1C:(UJ)R1;M0IX3GV
MT+S>Y6HAB3 <NVS;,R#@>!V'"OBZM1'$IRSHI72)(HYG U\ M9MI](">5WD+
M$W==,L9IJ&D@GY_6"QQ$QT%RS[Y5=UCL,,#:@AN!BZS#$(ED[0KFDZF4?TD-
M.'D; =QB+F F8")GSJI,-_:_-$O499=D@%PX9)OTGG$^RI,/7(?$[\/B5N<7
MRS>I<E-K1YC790,JJLI^[5;X^V,:1Y.[:? =W@N+BU(% R=6KTD5+YXOZ>;"
MR^ZJ%7GA:<^XN7<K#^?YUZE308DY,F#3Q3K?YG&F6XC<)+:Z#>/\H.L;I37R
M\I^!C!: 2IRNW>"LV][V^W[K]CY<%*44:I"=M78=D*:,_GUZ-TP!NH?+!I (
MIDBU+4.X8<,8.5E+TH,%316N/DIZS@5)*1Q(T#P2*Y>UJ-@$<D.R>=V3E ))
MP]+I'E[9+JXNCBQ$ (9+C5<" &4/>O);VBB/I[MI.O$9R9(3.T[-.*Z\UB)9
M)+EOF&&'63+Z)\S'U#^YR]BWK3S%3M!*^W[?D?=#%D;3MG6B_,IO4QT0GV8L
M-7-%@EH$S,6^*F!,'7^8B C==UK#)??%2:1=.;)_P KDM=22(J,=LZG86LO@
M;7!6S/0--/;FZGQ;U\W^\$9,-%=\KT#V2LVPOF-BG6U?.B"=@&N''3=N07"I
MJF0?N+1J&;.Z^ZQ&D-5XML]J:%;CV3ZK\5?.:GS-[=M!E-SXC(;-J7).X]C!
MF R;2=PQO2JZD12?=VT,CN=N2-O+I70E0;I\)3)3H6"@FMY0&U^L4::NN7R8
M.D6C-8415;!X4?'<2WNJN5])F5.E!>KQ%D8D<HUWM-7+-B=E2Y<HO-=04Y8]
MRJ)_/QX=XH9\G=6-IG"ZFQ'#XM:<%%"9PLC*2%LI&=MU1@&WY9)XQ"A>DG&W
M,PYQU S)K"*PGK0AA24@53R!H&W:)0EJ6V>-L!\@\B>_HQNG4KP%F]]_X>%#
M7"?3!T'"4"!M1KR+C@W;J1F:H$&6C5+<E-9(I5$-^\[<J"^<@66TX^W%9PKO
M'YKY2VY@* O380FB4"<OF'-\0S9E1)7XKN-J30;5,5F#T4QFCRE<<8YSTCB:
MRO[Q#N_%*\7WPX":+ZEV7C;Q6P2A-S;:2&+=.V\<R^-MX99TX5:K[QV)C\>U
M\JK1U2,7K<>EHCG @?,FD2$;?R4<MY/&9@.0X);G2ZRC0\';MZGH^40V10ZZ
M,'9C#*CNPGAM$H.9]&(M-#)LR)W*3;S#[$X3 5+^L^PYD/U]D4H$-IM3SQWV
MV+T*#KM1%VD.;U"5!7@9AMZ&@F#T@\%N*^2=\HN Y$$E0R'&>9XF%;?M$E@7
MQ=[O8=B8W2GSB<%<+478W3<,L['N'4E?%1C]OF<>]AIL0(,=4?F_8TP8CTZ8
M1N4BR;$W[9]3+?)G\IQB?;Z0;QLJ/*;0086L#1>>/B/*K'JP86&?EL0P$EEK
M<42^#G)XE&%"TQMT'#'G-FT< 7#UZ-0O<4T%(+9(71[49TXZL&'4P1H^('\9
M$0#;%CB@1ZR'&M,-+N^, %1$&I$*$;0'-:. QC7'?\NRF]@+Q7"YXQ.%C755
M=Z98^)@5)_K;!#7@#,OJU9/:%)DFXLHE!H]OROR&03G_@&>0:7J.<V:B9 <*
ML1F\0AG)N.568N$)/LYKWG$\P@PL'0'IETT1+2RF0% O3B.+*)-#XL!D1<4[
M-TB]C0/!2:94'B6A.,A=J8^32-RX4R:MV0P$<U  S<6]DGRP104746&[ @J0
M\B@89H_] 6+O64F_@,J-2SB]*D=&D,V%Y@Y,-\H5CD>,NF!>JAM>;6>EJ/U#
M/ZPEG^L<@WJP_X/V&N/]QIT5/2,)[ 1J'=EBP!B/!M> <XC/IXH*\W-@WMZ^
M=_BF)IPW2SE/A<R4F%C%;O),<<DGEH;))WAHG -;A<Z/H_<HY^SBR,\XG\.6
MKL-R,=^R0R_F=[Q=W%^4.,<E$MO&H<-;J0]9!.G58@A0@_-**5@2$K7L7GP%
MD@KMDR,M; /5$6.$V]EF&,-'?4.V&67FB:529@3L5WIM[N,G)/URE)/F$8SN
M$0]6C^\RF9/U*7\3%PEYLNW8+)U<9-7W//<-H01Y!3V@A3< )[QSF3,E.*F[
M 0KVD9R\Y!(KXJ"CVL"TT Z50F0E=R7)YFX;WH/WG9@^.4:T83/DZ -KX4\<
M79>W2)@I67X^(K_!#H '5)2!(,'/#'-VT_:?3F[SXY;%["%=%B+\(KB ,S"H
M21)2YFV5V^-1F-KM$E8BG(0ITCM<>+TQ?(S$P[$@2>KRO?J2FI\B+K\[FU<(
M&X\1"D 3RG/0OR@4!"KT@ R5G0+[7^P#^QK8_V(?V/_,=C#6+[5(;EAG!RPW
M8;^3(R/%.* 8HG,8FA>=4"^9Z-2X0XX[UE/ "&=-#_0.5(+4-UX\^DI-:I!6
M&&XJ*T;@";)L'S<8B!M0TY03I+C&]MAITFBDIUU@\H9AJQEB9&D9)F$OH56Y
M\#EUSSG9R<)/O<X@G<>&&N'DE<E*R@SP3\1)1H:GBHI<;Q-M-=WW4%?Z8L)T
M/0!D 4F328V,2N'+82>.)*]+-T;M6\>W7 NBW':4[*(-7N' <]#<;HA:-RE'
MQ@_5E!QC?DF!+*1!J3F)$AFTBG+:?4B(O4SX51?N/CF!"=L$7PEW74?Z4>K*
MTD/GW^".B ) &4X,CA%>K&[7?PI [)8S^_1.%5ER=>L>2D?!D3]LLD3'%^][
M596;=2\SA[:WPQ+U6K%'!*"]*36/$/*L.NJU_?$?./Y$^HL]R!,TX"YMO38N
M[8N0[D#(4UK[Z#>U13,=?4+^$J0O882IKYX(R$LBX2XIJT[>,Z@?X*<CNRUF
M"<!UG6\:-FA]_\V2"7:#2IZ+:ZR<I[@I^1P&RM3.)!C?:&O;#C<// HGFP((
MT[8N':QQ[V&=">]6H0Z%R?!<<QJ#;%/8>_<[I/<C"F;3S,*1,#\]>"J=R/Z0
MO6"ZTG(XHXZVOKWPEW9>OX<QM24N?]<\,#U/&Z%-FRW(^'1X0I>R%3 ?)T3E
MD>'(A?>P=,<RT5MY!G6R0R,-WI"YX8-2AM9$*:,S%M\EU5T8#?5 \Z")7IL^
MI=,M#.L":C'<+/C/UPO=V6JAR$4@A(Y:D9II<86V]E9."89C#O#>&&?>MYUH
M=N":_7>>I9BMWF &+3R6NN*(F308E2:%_5%3@Q?,02,MT/:6=*DI!&I70?F:
MH/XI_632J8U\^0W',I(V%/VS>A^I#V$R-XBH#/AMY#@/3VB[DVO5C>WW<T7O
M]HX$>S4ON9-D< AQ5X;3:GI-&%_ND_L(#(ODBB83$:JT4#?I-:Q.ZH*$:E'"
M(H&67)9YAJ@6_%E5RS^\]2K<'A[BW^5K ALRE2)84IW=F])JP2IRJ#9R8LAQ
M$IO1@H4E1>^VY'1HI&12<+!^UX'&(BQ%;OF>2\D,/E/&64)<L]_;:\=ZRA-Y
M?9WXH0'S2M$[>01Q\,8"GZ5!L[%@+&$<;]5W#O>!N# 0]^4^$*>!N"_W@;B_
MM&-'[2!.)%\W'A%U%/@HJ2&/T@K5-XYY6*_71.I"M8=K[QKT6)9V8MZF7;NG
M^*J*LMMN@"I)%]S[W*44 YPJ1IM,NC9/K[!5,U<VQ2*T;;4E)?,PV"#FAS&?
MAH?1>GI6F>?_; %1SK'#3#+7=.+YPVI4)(*#1[]_5%;9%7%5]\QF9S3,T2D$
M\A0\2Q?P;WR3JTU"P1YI;4MOVL!1Q1OZ[TJB*@>;XE=Z_ZG&OGH>3JML9V)H
M]L<C__H6R29&4UGXI+NW?=S&\($@X7=L@Q #<].DO='QB0W%*C==(--2N]8%
MK0V'XVW[&$^_*'C&HD#1S;HNQUJ#SA+AG:;3J>G":I4$88JWDIZ,-8P1H"!X
M+SP].HR/GGZI]5VUYG';[4TPCG.\N8(QCT>/GU!3F?^_O2OM;=O*HM\%Z#\0
M03.P =EQMC9),P9DF4XTHTB&)-<-BF) BY1-1"(%DK+K?S_O;F\A*2^M[3B)
M^B&5M9"/;[WWW'O/>8[SIZ_L%,RF?\-O;L#O.&HJ#Z"GG&9]P6G7HB11U>5;
M.'>8A5)98BV:_>%R0FWY:6?[[0MM<<+\$[OMA OD0OJB4;YYB^UY>U\S3$[S
MF@FVI^?/WGU-GBOOWAZ.NYV>[_VVC2W8&ZH6?.J..GZOU^[[@Z/1>M'5-/'U
M-J9CCEGN)&;::6H52*HYSC 7PFEQE%!X9FRL/K]*A=5*6C95]N2%)*8&%1$=
M2DV[4/Y$G@)6AS$TA.6LB]2HT.@%4X7O5&NEB)5Y2GG%&Y&-V,[$9Y$.*-VA
M- >N?L5-!_Q<.M M9;!I/ 5UQ-?O1T>'N\79^V?P_TV=?PV2DFZ*GY41^"N,
MA*2!P#"TX W.!J&_"8'F[BW,H#&:%U"?F:0R"31A%20.2Z0K@[D$ED?0EAG9
M2'5?? W-AF]BV6 T\B 2Z26?2[X=TG84]!)<\F:F017EQ$%:V-P. ?G>E7)S
MC $@$WIX'@M>+77U$WA9: .($][5+[.")GR0L*80X@+Z8ZQCUZ*I4N>\8"*+
M"8)1TFB)YQ%^JAX<T17)QZ-P0DNL+EJGM@QF)=!09]W!T\/_QU)NT,:<.>R,
MC6J= -"H65*<4'43V38_*4+.HRT0FT6G(,^M:+YEJBO3OBA0-5M4RFHBFDY)
M&V\Q^@>(_ENHUF8+$@3F"Z\(_HKL83%_ATN"-:/SF.SA.@T:W:'<: M/J>BU
MK9=S_7+&Z**?%#$(^^H):#S0>I4$U;^G+(]FXF:DX$=NQN1,67.S*)?DCI9$
M."1##U0LW5B@&[=GM+N$RTGJJCJ%8$IR0CF?>_IUO@1RPB@D25OB<+ J[^$K
M+HU9"Z7=/$/UX)*^H1\J3.D%[B\FE5KR#*SP"P&B>&C.HXS@6KE":/JPOL?6
M@)\+^+U9 WX"^+U9 W[?\E;[BC1OD+Z<E9O;%FD?G9HF*<:5L<N92@8.O-@!
M[S*+*)#*2+64@O$T;'(1X3+3>!#RUW >\ZFZ 7%&&97.U):KAY+C*9'&ZP!C
M.J70(I.OM;1"H"BFE1X&(EK&G#B/ P_4(P!H*PIE]5'\D:FEX , &C'H%MA(
M$S<K5ST?8,+[ M71Z1K\])!U4E!8EL617X-R[@*4<S=@A#^GV1>O P I/,DF
M0A2892-N"_',DY7W5^$X-*4PZQWU@F<Z 3KDCGH!H9<PD @^\Y\ZCP.\0D$A
M+/YN/S4;=1V57'IN3TTV)0";0GCW!7J#27A#;U!U(#PGQ42GB.""K7FT/=KV
MR-TC?:U,7?XT00HP")LEZ/$!@T\,,SW*SKFW@9^?ZGFP=D&K"TD,3YS#B[-T
M[HR4K69)2PJ7!5E$/ HH_6/_2BB G45KF-)N/V:UBD#0YR7%%#<:ORJI\\XE
M4R2;UU%,<51N'D(R96W6UYXU""AK^#C_%3!EE'32F<*E'-PZN N3>,,6I_#"
M*\,'RF17<X)B11@6-AD!FLB%Q.O!1(>?"W6H(1PU-*NM.K?2%N)$BUL"Z"%L
MZY" 47BO=[:?/_6P=$9-8SJ?\$(6V\)A%FT=++&I@DVC"A)1+-C)'3";)UE,
M4B)MI@BW$+NL)EV#DIU;[KXB93NXN42PF":.K BN .IA@ QD,) %&A@PRZ)+
M\=2EI6V5,JLSR;F&S%NH6,8,!LHL1A,CA.&'OV+5OU3E9O'DJ]]C6F])N6!3
MTBE<1=F:>]!5H[#NHFZRNJ278_*V%?;":2F)XU.*NH71--#RTA6E8^XT*S9%
MC*9X/:U!X\YM(^Q'!@_M[X&P7F N*+4A%HDW*J?#.E[=/!Y#J6C3#:WYEE2;
M7M]:H4_2H4>NQ9T%)%#E\ +;\*:&7DQ-E\/E2@6#20)_J7&*,S=&9$])_#61
MD>K"=SWIL%">GPYG974BF..D,O$"+J_4,"UC/Q:L7>&Q([KD\\C@@W, UY#J
M</4UZE!P+52&_<W1XJMDD\L-M^<V=9#%$:WI)&N#J%;M#>S-AC8W)NP#K90:
M,0_#8&]A6R4.K?416'\$_NRI^QWM?B2B:2NIXHS?$>)%S'0D@T@9>3%5*6-4
M,DS13+:XX -<<RM2P^OJ0I&F:1X3BWA@6 =,.H:(P-#B7X]F_6C^0N0I7#C&
MP8=V#I:%'MKZ?=Y98UA0DR"[%5>11TDTC8L2^BAK+,Y,L5HNN#W[V@'=?!N"
MA6Y9-KI6^&EYE@CW-FU<:;8B+G@C:??2=D$*;&!?!4@<CLACMEFFE8;V<=O$
MAI]I]FINEZ5A[F2AX\ZL"[^,UV3M6=0G>$P('U!>PN;+A@V%]/C+421IZR[I
M.HRCLL7"JAJ'SFM6OP9_S;[1R279FV6II94Q*/2PA%[-RFRPX@B<T[!>IK7+
M] UA7!A S\(M8J'=PS4V(1?1[,.'LX!-8@IE&5\9YEX6LGESHG^]BJ^80NB6
MRHF3].TD9;_<?J[/SYM=Q3(@G.N\J.PX=85Z9GOAF<C[BV!3>INQY&RNVW&D
M*A"VF>I]R'K$9>Y46G)\Y$393>R-0""O95FHM+2U(D.0F^(\-XAKLR_3$SCV
MS9MU",,-8;Q=AS DA/%V'<+XEK=W9 7^0* K)"KV@@OF 58[MQK+7)<63>@K
M&CV0;(*6=ZYN%**VEXV*D&&F9I_:DUVBU?JC6A\6I]@:23(@/E6I:<9R3=[K
M5B2WXCTQ@1GI(QDY*AB.E@B!H5\D*-1H.$(JR(())T6X@1)2U 4E*LT%N0(,
MF;(\%&O"S&D6#D:_I-1];K?DU7X3?8KT9J)D%;_%85&M4RL33I^*R@L_DJ6(
MA.RZ^B@+C#);LW$#E42C1:EU$AUA<U)1M/@)N(*7(,C9,E<WG5WJ.K!"U)%%
M-PQE_52GY.I Y>)VM!0X05Z&VQDO+JN*E75YGDZ0+C5?GLQCD[.D;ZT63Q;G
M83RQY^^J5GC<"-9*J+:BY>VEQ"BJWOP4)&<0'TCTD1^$*%[F$"L '+/DO#H!
M+$O9,R+E0_)EK,]F39G2C.&G3Q%7G"SSW @66.P2=49Y#>9YU8IF.<UJ;S/@
MQ!R\O'JX[ ^*LS)-:M#6X@AF-9&!@P(:GA2OLNU$"I:(4^6N-&MY& 4<@[Y1
M0V?+4-7=$RW!.>!B/ !@LD'2F  ,4+27<$8B>5#ZM]=-/>J+9D,:;^)=4TGC
MTKN@Y-7)^\3VQDSLME)0[4. #QDP^:ZZW.)2Y]A J)+H7BB["[ 38 )$2C>,
M5()GJR-S.DT+Q5B]"'P_3GN3CS9UZBSOD05/<0IXZNIB[#$)MP%[9V$YJU;^
M4J7^F<5GJ*LTZ;R@.J=I&G+FD&:-7]&ODCXK&WL_+1=PT^JP$M9+2)!-P>%0
M<!'OO=PLMMFM&;MU% %!?D/DN.PT2=D28<ZU)YJ PQI9 (QI<;H^PM7>,48"
MD)/8D2<I)R:7*FYI>*Q::E8V5N?9.<\NR:F\8BY:Y3GQ_ 2D6G06(H8LRQ>;
MZJ-HI79ALZ'S2"7=HBP>:](_+7/!4H8!)$.G>GI,H9Y;]!$K'VB-\JW(R=\A
MF$\M/64F<I+,^'I??8683HX7BIR<=JW9;"6/%DXQ[GIP5@S.<RY8I FN1Z<N
M=,Q<+E2=>)$2$51&LE]@S0:8?<W0(X5V+X2D/C'9I9:=1]1/&+"-]" B+91.
M[2106'XS 3)3D\2$E[=O;V5I4GQ:$S#Q&826M:3G"*^352X (@-\IG(Z*1PC
MA@M&L)Y$K7DT.!@1UFQ6NBUJ'^<4JW,GT<,DB#BI0JJ=TV"" E"1DW*$-1GJ
M(;;P$)893A0Y F5N+\*I)AK%# ](O@DP+:,E%S"L[J8)=(2:/^FP ?8I0.S0
MJ\,^$[S=' J:!X ZEE/BU5>P?A(%W/-(.(-*MXES/9<VS3:,'2@G6*C9G'.=
M<F7Z1]VB^N3@ =BY-YY+Z6\^1.%2$+"3VM%B'::Y<H_ \I 14@R1A )O$VRH
M0.E.RXV%,U$#AL*)2*4^*24&U'1&E5?D0I'//5]$F![E&.T4,E"G-4Q+M5!G
MZ&4K)_0\C4/2L683"(R#%N/!0 ID*89SX:NQCVP>)**^U0VVT[N<,XBN"OL@
MR#O3I*6-2G.0RYX50W664+-)S+G%$7M*N.$G"K1Z3 VH3!=;ZI)I- @S5KFV
M+")6O<'L]FF<,%Y"XI:0F3-#9 0W3R(4!X=K<A9'?*+B(D0/Y@0RZ0NZ@?Z$
MY>L#ML#+.(2NY+*G SA8M?-![9 \ XCCI(@72[H4;=/ X:>3.00T26PW7/,!
M,AF.,L#3I9I.> KHX\K, R+1O-4,$(S(95T4.Y )0G!PX3$H>U0WO3)7O=JI
MNL;6'6S]Y<X:6V=L_>7.&EO_IH_.ER2YMY"P*-IMQBTAH)W/4<9;)BQH8.5:
M,KPBNX^5-Z2VS[FRNV9T>"AW"*2TBW06L<2IND1Z"1]54GA%>1B 'A2UXN.5
MR , G1&E 0)13@A8@=V7BFY#RKX@TG=;;1R9AMU\2FXC<&:P8H0WBZ,EIP26
M+H\706V)0-G9%ZO[Q1+:Q:9(+C@D4@@@90EBY:H!N3(B43JIS!HV98TS$N=5
M'TT+W8-+/JXP4YRHVA*"K:YI(",EI+,=9Y/E' Y5P+FL;,F%8$;Z%$<-Y"S<
M(M.:, P+F)VH&:<F:79I5&@W 35-)T0_:X"-LJQ#9B;BVC>^?O&^HL4[C\)8
M5_=T7:2,7,7(XOPW:9M@*%+RC5.\@T0PGG +$^AG$Z%")82 &,S<SX73-60Z
M9>U-K)POJ1"(U+I3GVQ4UJ[0;-:94V"PL[&CQJ: N<=- ^N'&/O O@W5 45*
MX'. VP)KN[C$I>547].,%S#>J%C;T&.)1'-5Z-"$&5@4"+.9@IA%1Z\*+2!@
M7]=%=@:MY?@2T$31.5;T9E4&2%\/+L@&Q?HKZ8_U"ENQPK"DX9!T[IJ-D?*V
MV@ )<3Y1M5+&GNK,=FID\C(M#EY5F+]1-0UNZ!:I+)OHN:5[!$>N2:HK=$RN
MQ:<D(DW5]G!X;T%@L2$\=.)IF6<+_4@( '$G*H-&P,;26W$<QY*_-,V")=0>
M<T/4@1I!N0U6!*$R$/1S2S8;)C9%BN_3-&-2Q#1C)73*Y4>G$O'Z*99=P*^1
M0-ZF_$;O*<T,_Q /5PL%>-1DB.BND7#)EW.5>&?"#4,MIAO1()P$R9=LN2@F
MO)E2>!:T"#@ZB^].2!H&KBK21N@SEX38J3PB,8'@HESA08_(7"5NK,1CMA%M
M"0G(A,-E2(Y @1W-$0BO69&0\U@4E46Q,W1AAGIL#&"X2];U"0V]"U)72CRR
M--?4)$BG4_U]5G,*UUO5BJWJ9]BJNNK-182?-!M]@A.=.A@.1'D#ZPB#$1OB
MAF'R)$O1M5+>KUD"M?L4;@3$^ T7I^,7";\MNN]J 4:I>*+%)^,*^N,%H/.D
M Z=#FUI4VSXE,PK7F;>T-.[U;;CF25>'8MF)N#K+I47V49**.BY%(LHT3^9P
M,#DOA5!<U$1\K2!S*9DTR#E]!O)=SN(%*H:)94Y86, #!4$!J4#2#_$%$#N8
M#F"]75)%IX#Q$"M;SA=L@E3D(7!2V%'HJY4>JE0<)3-'GUG7\$NOM!]=BOIZ
M?:S8+"?("5''8R'HJ02SK=/V&N%<NP(IBXGX9EE7U@''U5)7!U2F3[-AA<<Q
MA:UPJT",L/+4/;\,PS-N\##0I,(1)#:MIHZ-XRPT 7&=.<)R)<K;*'4B<'?A
MQJY#IS0,T$GI16(HH"G_C F3L(X2 ^?GL=H6;;&2ZU+R4$P%BK/!4*=%',[C
MA$6!SJ.:^IJ:BJ=2 IDT"U':"<2)$EI64F7ME@\3R3?I,#<;O:7RA[]<>GM9
MFGY1VXW7ZQUZ&Y+27\H^[]"=A+*0"PTH42U7_LB$T.9"G1S/O6.(]+4IB6>D
M)LA9"]\ZR>+P5-DL_?]X.V_>O-S9-CGND)QBW<8+4\YBTL-C9TC9:Q66>3*S
M>/I9J<5MOTL9!8./\2Q:.^Q3DA:Y75/KQ--(X #N5^\WR8[NC&.)RS\1BX(,
M)5 *"%RR"G@=Y2+D&*K-)-54;.6'%]3?D(E9@5:=XL-U)!2ZM>5Z5BHJ4+*I
M%=!U=%7,X1FOYMD+[,,Q3V=8^6@>?S4YG]7]K+E'.8O\6_ %Z<=X%V6$GI8[
M91T!<"( S]<1 (D /%]' +YIOP&+''NQVBQ#HMG<)^#,^ )E>2/;""L,/HQ@
M'/BR^EH:@]/T0@&3&Q )RS48'T0 W"+Y2GJ'L],9(TASIK)H$,:F$\0"KFBE
M2<N39NIL'?!?XXJ6#K8  'MC\%K8.OJPK$MLPSN4>:033V_:96 _ATL.XZL^
M)S46HUQ"?*FL<+OVDE?,=JP5'(%C#**^ZGIJ#L*+9N,C;+CX7E1,MF'V0]P+
MQG0&C!]@22\6X!KA(!E?4_EL%H=EH!,O"9M9Q)F3+$^)M[9M(D"[F\(K@+6W
M)XK32':$P \1!="-A"08'4>QS^DF)BL.,3O-.H*44ECO1V:]?8?UO%DQ;[ (
MJ6/5%%EYHC51""L<@NI(SVA"N#67CI]!S@]C:P!Z00+8 D@NEDE,A!OP%59$
M6+%?!@E%4C$\R1E&": >,R];SB*N%S(LJP(A"I,QIP &\Y/X=,G$#YE$7E7+
MTQFB?Y8X=)@%T\+D0'/DEF<OE]'HT,AM:JW8<]5L%YK5$_,6Q5ME=PX=<HQ)
M,8Z,9-.XEC)FH]=2!"MUN%> 61H8L.HUH R&E7:FZ%X@:0?5VZ39!11KY7CA
M?#%3SJ7:7>C/,,:P;YBW^'/E4YXPJ[1]_F :89"YV(8Y\4S#<<@0&K6(X837
M[*N+^GP32_O%CO=^;U>M[N-V]S=_V&P,#KS_' T_>^-AM]TC*PB0U;[7[G_V
MVIUQ=]!7-SWJCEO>8.@=#@<=W]_O]C]X_!7UX^YHOXM?]/:&@Z,/'\?>WF?\
M[+ ]'*M7']K=_FB,[PS&'_TAO:^>Z*./+[O^J-GPVYV/WG_[@V-U[1[\?%_=
M8>SWX;KM7@^^/L!??!CZ[;&OKN?_#A][A_[P4W<\]O?QKH>'O6ZGO=?SO5[[
MN.6IN_GP]MYHT#L:^W"9HWYGT-_OFNMVAT/_MP'\Z'.S ??U?S\<^J.1:@5V
MTL@[&*AOJ'9C'\%MH,=4/ZG>ND=)@G\XU4JJ"?<YX\CM4K?L[FZ,=&+O(5IV
M!TA"N/G^6?>!^VG[==6OOL;/?;'V<\7/?;'V<V\XIQ[RSFK//>Z.^VIS\HYA
M:QL<M$S:OY6?3%@NX(.&.D)RU 3F<HEG(*2RG%V:-%T*)[@F7+ LSM(,64$I
M?S\E/4<YK9L-/(Q)TQ)J%!C1!5G NSN0*P,PQOT>U%A&A^V..C_^_63G"?Y]
MV-[?E[]O?=.+."S.X*L[3_6:!CPQ6.1J<LNK)S@SWX^'<H-S2#^;!#,94#7Q
MG\CL'>][G0&TLO_O)R^<)FWEJENI7;\J%^PR719;IUD<;LW34+T_BWE+AQ-P
MT-M3I^#@Z%"=7?T.:=(\&^^;F^@.4B_5/\,';*)UY[MJSNV:H,?M]=,GNWN7
M[]RFZ(WJFBT:"G=N=[N7<+^ZIY=;\O=^WG&_=^\=<G6K;GP1/B*&::)<A\_!
ME_3\*P[R'3W3&$*?[[S.61RA5AS43*EM;D#4"=_SFOI'N]#1;INKQL$=)+IU
ML(7?/9HF/K(>:Q=<*?/.^X-:4?WWST?36G_K4Q#/OHFF'IXI5^>?MO09V@^[
M/[QEXIY3KU\_7=WOQ\AJPI05*;#7(,BOL5PK)X?8'#97G,-\LU=7W>Q.#I:_
M<XY\E0;YLUF40"K@ARS-<TBI^%<P7R@W=7*6SB+(KWA$C:U9>'_>KGGWU+"_
ML>-^I9;Z\UMMMK=L9<W>5H<CW':_NPYQJ,!3&/N$%F[EQ2787&&Z/)G=/2!Z
M9</J0:L_AOZG=K>_[P^]P8%WV/[@N\"CU_,/QMY>K]W_[U=IWZC[H=\>'PU]
M:ML!H+!'P\[']DBU^&#0ZPV.1W_>,[!W*Q3MY1I%$Q3MY8^-HM5/GWNZR1]F
M5;A+9@21 V=+0OMR&LSCV>6[&TT88C].,]71R\4BRJ"04N"89J,6CWD(O'WD
M=XZ&78B?Z"W!:W\8^OXGM7W=W9[P"!%/SE)$4IEFXRO!G5X=VMELW#'<6=M9
M#S,D3W;[P=PMJ7CG_>]O_O=]=,C[[JZ)<*F.:9LY,N(Y<NET& 2^WC4;/TCW
MR'RIZY9;3YWOHTL09+RS/OE..@6]'D]@Q%6=\_"=<N?/_V3W0/-D]9= N'L7
M4^$Q/V\5&X8#UQP@WTK;]RWV0E$T<Y[$VXBG1#J'%'FY*UMH<*_'^[C[Q^T.
M/BOIN#WJMM:HQKWS?OJF5@;W<G6=/^9&@Z[?U-7UJ]FHC #)S!M<<+VE\MG3
MR1<H_5GM?1W'R2E2LC_93=EI\EYMOWW[%%(B;_>SM_"SQ]R5G,OX=[OQ=MT!
M1,#?9S?ZRB>DHW3ED?EXF[_*K;C=T/9+E1E!<EDNS*Z6Y&EYOZ3(@NP2Q30G
M9]'D"]5V0"5>^I<ZU#97$4ZC8[O%3*Z0<"Q2H53@:'QN1\JFV@K0S]8BHT!T
MX=2V<!VS?3/#P[B:!AMK'?,(*8F1B%RWAI_;O:#.<UXF6BN2ZO<]9BZG]_#G
M0FQLJL_CG%0JX%(;,7<9?TV*&BA1F<L0""6X7IVYIHQ275_= "G)M*JEU:BK
MU2>:C0U@Y=+:W,209+4?9\$,2TEAZ+&7-BG36M=M:"+GDGZLR"38\T(J0Z0!
M+9LAK-DHD7-AP4G\!5_KV809[-X&6%1$[W4RBS9U=-&;I<DI*&6PI"CWB,WQ
MF1=1$.(7DM+XFOFC:1&N>IAR&Z"<EOJ"RU)JG[+,0';U0S8;I3M0Z;\A098I
M) .^?X\41@^+V)9QVH[:W;K](_]APQGWE0Q]D\K:5P\5(7'B >;YUR&(.QUR
MK*SP_SJ+3^+":]]S?8!U5SO1_U[OA:+PIIZ(3=G'%'U\O5Y1=[VBOLKJV?N.
M5P_XU >.3_W#''@_KY?G]W?@_?ZQN]<=>YWO<,D.482+J]J)-LXX5S_,JOWE
M5V^ R&O^SNL!/\ C6L1?=UT]VQOL?X;\NF<?QY]ZN_\'4$L#!!0    (  R(
M5US\G?X$[B@  "_(   >    96$P,C<W-S<Q,#%E>#$P+3)?;VQB9W)O=7 N
M:'1M[3UI;QS'E=\)\#_4"DD@ 2V>HFQ+# %21\* E@B)CF$L]D//= VGK)[N
M21^DF%^_[ZJKC^'(D62'U"X0BS/3U:]>O?NJP[]?_'AVM+EQ^/=7QR_AOPK_
M[_#B].+LU='A-O\7OMV6KP]/WK[\1;V_^.7LU5\?S,JB>:9V=Y:-NC +7:LW
M^EJ]*Q=ID? 'B7JO*S-[  _"H^>?^MQSM4BK2U,\4_C3G>>JT1^;QVEN+N&C
MRES.FP='AR='KS[.S<0TL.#6WN'V"8!]_B5>^&M;-V9V\^#H+\6D7C[_TF]Y
MK2=5FU8W:O?[1.WM[#V]&]MZN:5.RBK-U8MT:1KX[]G9BR_]SH,?=M2/:6;J
MLE#'5[IH=:+V?SA\_]/Y43,_W,;_\N9?YV59?6EH\.%?RNI#HNR_8.F=O;TO
M_=XSP "LD1:9^ILNFEPO=/'L;A#5^W;RJYXVJBE5,]?PFVK!&YV6168:4Q:U
MFNM*FT(];.:FWMSX2Y[]JRV?'U]6&O'0_*6BOQ^I"WC^[=F)^EM5MLM$G1;3
MK42EZJ7.T^NTTK!BM03ZQ35Q+:UDI1?E8ID6-W:=A-XWN5$IOJ%&R&J=YZI=
MXC_3 CZ'+R[31F]NE#/UT#QB3.TEWQ]\E^P^V8L6?S^'5]<.1G@ OW2OK/'C
M&D!;+ "JNBFG0%Q_VMG:V=G95<NT4E=IWFJUU)6J<:4NX/C4>WS*O@%@JM2R
MTH]G;9'I3,'.J[1H:@4(S(UN$0*&*5KJ')YXS4_\+$\XF/$T'AJ[S1!4M6RK
MZ3RMM7]-'[[-C=Z*@$?W9!^M".)^<O#=;O)D[WO>=HV?A=L=PH.\1G50GID*
M""R_V=R ]UREE2G;VKV^ HAU.ITCH5A4V*]D!=Q_ B>4Y[",N=+Y3:)"S+F5
M_/;F0(&7<S4D,)/-C;16YWDZ)>)5QY?XO]%1Q-_95;> ODVM'-G3L>!C63EM
M\8-:Z8]ZVC9PA/A5IG, MH*_@)0#FK//;6YXR)$X@-\*W" @\MHT<WKD[6P&
MG%Q<JH< <Z9GIL#E=%Y> Y>88IJW&7R;T -EVP"!+6"?N ;BLP9H*F!A[='-
M/+7H;5F^WMSH<76"! #<-]'1$:A* VBX.SA4D0\ 8[#F!=!"G?*&7EH4;=DS
M15DA;&#Q&%,1"!J6&2/OC%_VWFTU>D/WF!<I+M*D &P)3U=J4I4?$/_ LYE.
M<_PGK@WR$-:OV\GC%)^KB:E!" $D.GML?PG &CCUB08$S6X[PBT"*&2A1 TP
M/6&C@PF%B)@ AB]1X,V&: J GNJ*-F:**PW"@8DJ!5%DKI"GEPX5^,(*5 0#
M^N1A^NCAGA.,'I'J&+  G^[^L+^?(#I2>!I!?4C$VT,\_CX46=N LG?ZLLU9
MX+\$2,I%FZ. H?.N- &2>%2Q[A% 2DOZL#6@O=JK*=!J'W03Z">@%$!:H2_+
MQJ2LL5+ WV6((18977JPI >@U4LFLP!_(8?88PRD 4%;E(UES,T-X0-FF'D*
MB^$*"YT6N)&TGE9FPM0+GR_P? @HRYN.][;NAFFQNW7XTY&7E[#M8V:LSC$<
M;O]TM+6Y\9;1,4EKXZB@TJ!*:_@-GVMB]9RUQIPX0Q5>(/T#?@U*/_BR7L.T
M*6=(&:%<OQ-VG7QH@,-PT9VM U,\. )6YY=?!**#C2W@H19T2&7^K>M!5O%B
MT9"F ]U3([ND]MNZS,W4-,RXM9H!^Q-K6>J&$T6V0.LHK9H!>3,#^0 V0@#:
MB$@%;EV6-1RTDQ']Q5;S[D] 03F+A[RL<867*",#+;NYP6H6X=5I!99;!982
M0(%49 J6:?3:R": W=9MR@@1"<L8_RZ)Y#6+"! >7G?SS@R\[QKVT&C:.Y(^
M6;D#1Y)XE%=P-E.]=,@/[;L.8DCO71OZ(BV<J32T_N]!HK\C<TQ6,<?T0U%>
MYSJ[)/9(FT$>F:.61%K(6&'2A[''D>#9M(!]Y*)*I^!7IY/<D>H$5(_2,V >
M9ZT'O"7J?^7Y(A=%I%86'>G7$8N!,*Q!K>*KYV+1;0T:442[FQNX"?1%=#4U
M\,%-N!O9 =MI(,X;U6'K<H*R&AD//"OX+9SC5*-1@[Z TXC "O.R%EL@VK3?
M,&C=%&TPX!?!DK>.AM0],TK/@DK4I!T^U(!50>HADZ4A%X$PNC(9"@Q2YZ$T
M2-!P*2= >VSSE. *U=.\E$,S2'ZFN2')"&A9E@U^ &Z*<XZ0L\F.P.]SDTY,
MC@_(R07XQ#_U%0D+$B\M8-$AR["9@N*D72P(%I3.^$,^,Q2(:!,68$6:"DSU
MNL'SJ$$VY?D@4KH;(U,.Y98F >_<"7Q'2)SP)1)^>5W@090M'PKZ,O;TB";D
M^;HOV(?M.#XCU$^P"GH*XAUTW'R Q]$!8@1^!1*WF)IEFG]AF^L/)^VF(NTZ
M\1\BYYJM:JO>(D6VFZS2\!UAA/X6&N^W,J85EG9-YRL#01,Q-X0&/#@D%?P$
M3/R6G*-A>R4#'H0O,]@-BJ05HHRD6%N8*9H ,6O!7BN2;65%_(T43@XWB:E
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M3_&S25F!,> ^.P%Q\D'M;ATL23N;#$ XCU>D380X.=R&MPX @.SZX?%$@YH
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M;)-:A1R))-NN\RAL>T\#1X]ZI+$J+[52=&; !C2H AE4'[*5L0&\-3!9:7C
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M3OE=:SNPGNSONY$NI?13X[>UD(4-&=D4<!PY\F8;U^GA(RX6)AD+F\CETPS
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M+YW)?4+L6X#Y5U;T.%O;_X+#$G<B\,#1)XC2W<[BBUCX/XCBX"C(K.6,8V>
M.W7)40$W.@?Q16W(@FT1&:GTSKK%0*L1 1$GW8*(6>3UA!W!82(JJFT:2*DX
M\RRL@W"1_09G9)&--VIZ.50[(SNXT'TM*"(KL1.27K?$*C"WAA-C7'GV!3)C
MM4N-L?_'YC,04,N=#"ZP[MK6PDM%@LH"%S;Q4K4I8TIVD2EY!*.#XD<%IF_X
MR*.53O/FA@UH^'PBW]['3='ELJSL% =3<]0!]*'<K 84DTO&3:JNKUQ]Q_C5
M*9W&"PY+#87_>WT7/LJRH@%WQ?T:,JJ8Q7ON9M7+?8I+[+EH;%E3,#^!NKT_
M%2<T>HUR52/("8J.)N45QSG3O"ZC![ "3>Z1N 6%@PF4/@9'PB-!4B](BLF5
M)C+434+,48IV7>%"!':-UY]@A96+YJ$>O\*SB@0W#7SC/NFX64.V.3 ?%H_8
MA1'92!%';$ WF%G,5#V*B23^4\Y6VIX<IF<X<@4@IC2YK_3E<\+0TI"@P8C,
M)']@?\081:.!.\9HC(>O7R)C< 09?:)A] 3BUN?=/EWPAG)B4,EP\V.7;OLW
MTR"9B"4T'B@<%-@KPWJ!)L \#3<(^T'78B<'(7#0/L9K#A'9<>]-+-7E]"YA
M6U5!7<,Y-5%-R0B;E-E-X@(A66R1)Y%*@%-.F[K$1"TG[5W2]R;*4Z\L-UB=
MG,8,5(/\&XRW#Z_[='WN,3$GG?CAZ.VXT02B4 WI4'MB .@C#09:+]7;:_V1
M/IKGTLQF]=IE:W*.8<^JM,W:'%>$G<?30=7#=6J(=MUU38.E1(^"2Z["Q,6M
M>M?ES!RL/$QQ!<!;ZG5)U^E2:G?\B&XOI (&[1[=9R^L9ZT<U7MWKS$%5Y&#
MH'4/9<,SN(*:J]&JK$Y%5GQ]E"W)D@FXHR59GZD<37#U.4O2/AV'[D997R-@
M*97,_>B9SY?P[WJ]J_+]A)0XX=]+A(JAVLG_2[OA[7E_RQY1ZK?[G.0#*+<]
M]'*.6R3K9)5[(*VSLA>@%*6@C++/NG_J8D[L,)*"2A]C)XC<^)2T=QO"^CID
MGQ4IYZ>H2+H)W!%?HM?VW ^H#P73V;62[MJ18/H=B5^L$PX_^!8.EW#XP;=P
M^%>DS>]\;.U"1E[=JZ;(*!0 0I,L/C_\:W3RF!@%Z038"LW?X(;TX7K+!)=B
M36+M<N?!<EZ TZS!90IBXX0W X#!XBWU*K6Q?5EM0>8.3FUT&?VZK6G 0!AP
M"1P(]!0'QCU&:7U^#;OYWKB1T:#Y#0\^Q? 'O^0D+TN\=^Y2G6V=;PU!0B7;
M5!E*#A+.M%BT"[Y$O+8S"AI^"MPRT#HRQSP$ "?U8S(?P:.6/QU!(7D%&E6:
M2+2<D"Q(6_A]NH$XX)45-)X!!T&!#6H * =^ID%OH=NC#:E=0>=/A:$8R/O&
MSD=':OVEK#ZPX6E+*FRQ1#"/2,;Q#X_B!XU((HWB)?4TS5TM+^RZL=7NSH%F
MML4L"(6*\89(^43ALPL3^"+@Y0/0+5<P4Z41YZ;$'W8CDU9?#<#14#]@A!'*
MUEXB98>:BR?0JLQQ 'T=SJ?C5BEXFV.FH.2@.]>QQTQ8>5ZCP6,6RPJM#8[*
MT>ZIPL25+ E@'=L<T8JUU%/)"J0XQ])6( VW?-UE@6A3%J?=.7B=88A16$QZ
MAI&$?(AA:"RM*W_@*Y9NXFDC@\[@P*%W)B&/K!8[C5Q9QC' [M94O+.1<O.)
MIKL3K"LDF;@$#?E96W,0"U:PV;K"&?;=\"RY9(ME'M3TRP@?BNC/VGR&'6J^
M$3N\^Z,WGU ,?2DB'6Y"&)A$.S)L2\6SMN(!6T-)F Z[^KJ>WLRSH#@NSCJ8
MP7%G$J_"4$CFIAI))9<?]"*B4 :T"$ F](5JGJI$1)+X[)UO"G&86,01+CNJ
M:^_@SHSJ>G#TO;?R?@1#1>=Y6NBR';XPS5](0U0^>O-.XDH!Z ^)5I2=.+K/
MRH7IA(&6N^&X$%UN30E=OMVZSP44.1C(B#=X*^1XWL>&7"J-<]YQ:>! &LTW
MY2EWK!5Q7.IE6F5<9>D2[6&XV#8G=_/[S"-\\TUC>V-60#LV#328Q$3!B0HY
MS0H)4T5WW=D[E5P<K5;678\Z>.*T@<]GU^H@44]I_]\I6]#GQQG5+1A45^X.
M[!O!2.:N>N\//Z4,O:W!3 ;BT>[-3T +)>'[XW=:@2DN"NT+$^IY+D7!/1EY
M1YBWXZ3X8ET>C4<4U9E,Y:*1/8:*_ [FNIB$0#ABZ+Z4Z2YI3:VNKD1?"C.I
M0A\4@]Q+9@L#AL"P!!<2X2!H,;DSV7DRY@&F,G=F1'Z,[42FJ01;P:Q"-%:.
M:2V=4FX#02$WA(HRJ)S7A=" =Z],U;2ZKY-9DM*UJM*G'B.3;M)"$.S4CW :
M@L^-N6F9:@%HS6]"$X1CD/(#6Z]^!1232:U06XA9ZRP2%EFV30I-$Q#PZ7)N
M.[>8%0<L# ]=:B]FTRI\U_";&*W]]ZGH=;;B_G3&TNRVW_?!,W6W;B;(QMI6
M. *W@Y><1_17O2PEN0LV%LVNDBE0S)#/4^-4D8S3]_TO'U$.&];L]\>"H<-@
MD%;Q4-P1\?2FC!M<KU-4#98:>B<87?9<V/RHK9^L? ^+.!@9)G2;MI(N#0Q^
M6]4MQ9!\Y?'$WA^(K"_%A8APG 29^YR*/7+R4&V# RDX3A]URE)&#),[<G3'
MTO$UU?9VVN@>"I\Z\,G0#M9PWC5'=-RUJB(D&YWKY5SZ.*B^)FC9P09G0Y,5
M_7I)4 Z Q3)5"9#PF$8;L/)5H#,W.::G1J;;I7JYI4Y*G#SU(ET:3-B?G;T
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M2ZJ3K'@1X:./7D9-^K5YF.39"7Q492>GS8/7K]Z\WOMZFAUG#;QP^\FK']Y
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M<7E&L3/8>L^B<80+GB*">WD ;*K@%ZZ7M>F8VS;QYH9=<>A1W3QTD^_>XUJ
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MZ1NF=[@;O-.=1.<5ZD=PQ.9@R\'/\A3^65DO,\]CC.(,>E'C>9K &$@SX*[
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M<AEQ7G#=:& IFI6S:TUAN,T[:3J*?N90"/+J>5$ZMG;K*;23QHY$!I$ Q Y
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M@W=DR!;7F 35PQP"): 5#W0T7L?D'&31=G3(9Y[,C.;"$K)3]5)3P0ZF>LR
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M,].[2/T7)9JRPAV3U!PCV3<K7LYXX%5M+P:(\S2GJEX#1[U[Z/HFGO2$WN.
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MH(\<,_0W. >=%T\H188PWIZ%)(V*9PQ[?8Z1^\(P:5C*\O0,$2R$W1N:#)*
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M;#NMJM+L_D:[8E&0508NIN2)Y:E.*ES6$-O9H-=@D5!_PW-<59#?E: B]%&
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M?_P+S#6T;R4&:I&?) ZT[#8YDEYF%0.MKG96[0VVTQ>C:-3UPG)G!RM?<C*
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M>QE]9)#G1?0!H;O[$M9]8RA_EY"87OO#FX_O_D/7[?NC7S^\_C]02P,$%
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M]Y!T_/6/U&SXI?,:.#T/MJ@R^%]8[??/MK>CQ=9\*]K 8_VUK-['D?H733_
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MJ@];@SZ"X6R6Y9G+$?L]//Z:F/\);&%9B#2;9B#%FOR&3U[_U5P"![RX)'X
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M&K6<S7'9-.7\6?0#?B9Q$_79;IZ MK"S]3VLM4:3!I9PXHY(KV/OSHOO8-;
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MY0Z4 +99B!Y^ &.3]#%;'@D,!ETY_1X8B6#-U$CYS^CCHU_/1M%P#N\^H;W
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M8 NX >24S[-_+S.N(3I-YLF%)*^2;PLC1&#U)WF#N>KX:FD"I_VGG7A[>SO
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M 5&I:MC,G >E0+!,EE660E ON/F$]#?R"S/JJ/X9:I<LEF/=1\HIOL>E!"9
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M/-\'&L95'OWMT6.]I. [OMA]>?YZ%!T?[D8_GQZ_/8FC@Z,]V-E=N.7G^V9
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M_GETS 5%GT6'V _E"[*[/YTI_-WN\?ZO>(S?O3Y_<_CR_P-02P,$%     @
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MX-T9?-T_P;6\/;O$:U^?G[Z519SWZ9-W)X>#VMW[!Y=XVYWG3YZ$01_^?CN
MRPZ##;SN;^GX7_/\I7OYWPKZL!?B.X3=3O_@X/3\\.CDU^/?P^!M'\EW"22
MN[ZFMX<WNC@]IK<=G%T&9^_.+][U3RZ#RU-:,%QU<'D$5'/62J\(2[E<LNIS
M^UZP#B# ;_VC8]H'EPXA7@SDZ@=P_Y,+^#5^@^N\>+?_[_!\N$%(SW 6<3[X
MSW='Y[2,"R12PR)P&_'&1 /<B6Z'=KM_=G9\=$!+H5>Q?W?<?W^QY;$<WL>[
M/>SY.[H![:TPV8#78?\420[D/CL>'/XZH-4<G)Z<#.@=U6J"_=.3?O#ZZ'
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MXR@!'EE%H-45Q\KR#%C*C27]:=JBVVG2!7^*ML  VKU0]TNU!0F>!E(_M+;
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M1^\)Q]&JP@I<'X97Q*6[28"ZW-4"KS:* $-N!1;<8X<3S<3>TT5]8'!3YWY
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MVC3*4""=-J@A'K2[NU:;2C>W=4<C$G0Y\YET)?VEV<?F0T$[AHUGM)U)P?%
M+D7T1#Y&';*$7W\XIOJ\=E#_;I'&:@<%=F.IQRR :9 IS4 1!AV15P6-(% 0
M1#**34T&1CD+< FKYH2!@=N:*MHF1&\=V;&&<BQMIF2#JRSPH#(/1A^R_#:-
MQU=Q:92:KYG5*-D[-9,,,ZLL-(*I/%:E')()[G8PTX'U__4\)YL1-*G! 2M)
M;HNL0S!:<JG!8*P$N?4Q=@1//=Q$N>:&O2M)[&?D3Q0<!1E\G.$,))D-?8)E
M _."MW4<1RE#7J32.8U(DEJ5T9H+3!;"% X*IQ 0QIBCHA!F,5<Y\P0G6I!.
M-_&-5!GX+?=0C?\ OV5DHP;<@7(X#!([)O(D:6SY!EO?8,P:!Z+6[,K4_TE\
MMRY4:O,XD4W9M$-JXE&"AV =,Q"IU&48"X-);.V2&8K29;5=$IB6[4HNPP[&
MT32ZBDL?BUK7MEA&Z#:J8*5+1C4Y%5K6NO6'&%A4W4%*QFVA'\H<8ON.Z _A
M(2>JDC<:.L%9J4<I98O@4%+S.SU\$?9$HN&S&:4=2:1+\HBOQ$2J5_A")!GE
MJ9J+0(ZMO-1X;I5&2&TFFRB&B5@C:2:8F&%VC<QC6'DM//:NK;Y\NDND;B\0
M4K0;Y'1HC4J3[I].7M*9$Z:G/>2%U6NEUCNNSN!V;Q8^)_6VY4[C@[6I<-<:
M$@:CZ%@017R.$[M@'+6#D5YFHBI[[(AZ-^&4",0*(8AO="<+MX:MM>T"^H%J
M@^0SE2X-Q7.&@PR<59CZO42#*DU[%O#7;Q)PP4WG$24PF8>N"*R=<+,?[A@N
M+^M>;U<-T*I4#VMYT]JHM>7(-)3R7(Y.,MD\-.$.345#KB&G8S "9D] KM9:
M&ZVY=^\/,719<->,7.)2-46*)0]J@<8>(%8/! %1(/$)>FOT%Q:U4',7-)-8
M+8O%ZK7"D;KU$3"-&W,TJN?.1"C-4!#;'%@MYJ988@R8Z:O4)!Q$+2I3-#I
M:?,)F8@!AT JE)9&M;+*9EPB1OR!(>%3 _UJ&/Q@!Z"D3YA:7\YVG$93<QHV
M9A@T-<K)2C7H5P<L*/<G1'+BLIS:9&6\H(Y8T:V\K?6F:][?^\#H(]4=NV2[
MOD^5[&+66U7!-K[<]9#"^@9;$I4Z%5LQ.3.S0DTCY(X+F7@&E3=?&'\/^S;4
M_=K$.]"35O@1QC[@4OQ:HSZUK%5^)_4*+ F6\7(14W B&VN[1 E]YPT66B7X
MY6M+2X!5)(13S[52;J,F7*=[S=JKY7IWUKE>E>O=^4OF>K]'SDX9$8CI5G1
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MX?+P4^]GR')Y:-WEX!2I<O*/1T\^F00@JO;W+M\,@M/C_>#7\]-W9V%P='(
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M2</PWF64K;I A'_Y$CLL/-C"'I0,@:;#Q(;)(HLT]I%JK=_"V8.EJ8X*@Q:
M+#+>/(W<ZE"<?*-[X8UZ(34#:T9JTHU42P,10=/H8S*=3]L7)S+.:V4OS9']
M*A &A8_G1>SUW?-6^4"56W^J!'D"$B3E:E:J)Z4A%1Y MFD2CZUR&!!/W,,8
M;;J0^<5,V!G&:7[[(\B=59Z\@\_]G^7_^1'L$NZSY!W&.II>'<5)+GV:NYW#
M]_V#H"^=<D_H7']EYOB+,D+3@M:$6!/B3R>$4D%/>R@'J P!),51=A.75<[]
MP+L=6\\D-*5+>MA&YB>)_$2:V*+F&<<35>E[KOMH!8<T1FV>7D7+.EBCBMMY
M_N0)]YEG;-P/ZU@X"=K3U\&;T^/#P?G7RKP^L&XZ$8.%>0JQ70,LHEB\".XX
M?RO_Y\>@DX'= +%,/\F /\^Y($43L=OY?"K^&/12?-5$JOOAK1^#3I2!^+J$
M^D$H=0@:Z?ZDTH])HY42,T_7B9FOFYAIV?2OFY(SB9G]'S(QT[] (^SMX.0R
M>'UZ_O8K9V5:W(!M9/0'.\Q'>QN7N935N8W?3.<*->F3RT=X4#;"P^<S['W!
MJ'UI F#-EMH*#G.J%)VKT**:YFL%'./&RG#NR;S5>_7XZ"L3_Z'H#.P4_-8_
M?C<(S@<'@Z/?!H=A,[4Y5V.5*9M2S$I5Y!:Q+L[5HYWSAX[:K.& +M@,\7#W
M!IYB*M_3S0CUTX#%^NR]N3=<W5V +H,-?/[C(^_NYRX;DD8X*Y*LZJV)M>I=
MOBTB]<=CG$CUQ:BQASFFWS AOQUN:]&JZ_/ZI13\1GFO9;5GUWD6FT3;MT#5
M[_9XW\T0WQ+??P>4&TRC) W6RN>'$YW?,)$PY#JNQ5SA[S!04=,U_=9,]F5$
M\EK*ZD3;BV7!^C5%UVQWKVRG%.MWR73W5UIT[S'7%7-2SUX&ISR$X$5PC/,Y
MOZ$4U5?+&M6(_7C_]/!WW,;';R[?'N_]?U!+ P04    "  ,B%=<I#WM>O<*
M  #.)P  '@   &5A,#(W-S<W,3 Q97@Y.2TQ7V]L8F=R;W5P+FAT;=5:;6_;
M.!+^;L#_@1OL%0D@.['3M,W+!9<7=[?8M,TEN=OK1UJB;3:2Z))2'-^OOV>&
MDBR_9=-K4B!%T=H4R9EYYGWDH]]O/EX<-QM'O_=.SO&_H#]'-Q]N+GK'1]O^
M?SS=+AX?G7X^_R*N;[Y<]/Z^,3!I=B Z.^-,W.A$.?%)3<25260:^(5 7"NK
M!QLXB*.7WWON4"32#G5Z(&CKSJ'(U'W6DK$>8LGJX2C;.#XZ/>[=CW1?9V)_
MO]TYVCX%VY?/03!4::;LQO&KM._&A\],!&)]OC@5OUF3C\6'-&R+DS0U>1KB
MWDNK0YT.A1F(7W?;.^*CCF-MTF8##^YDIL1E+$.5X"8A\1?[5:+S1&1&?)3V
M5F5/"A+S6F*RZMZZ>%]SE^G!]%#\"+%/O3_%E\]7?P3BTQ>Q+4[.SGK7UW2!
MFVBKL/)>]6TN[51TW@6BN]-]@S7B[6:D!%!M-AC6P..Z^>GD^OSDGP=XL"4V
M7\71M]P<XLLKRY^$L2+#N>+!F4G&,IT6#[<"P!OI.V6='F@5B8&&^L*1"/TV
M,;;F3D>DK+&<LD:P ATZ6I)IU&Q$>J@S&0OIG,H$'4Y-;(93X4R<9U KD,A,
M)*?8[@T@ C_0*PQ^))U@>\$:"!LPXU286YUI(#K.;8@=2LBA5=X<)CH;X1YL
MAAHROAZD=7JG7&9LLS$HA)T=32/A9*S(UKK!N[VW0>=U5[B1M"" -9TYDC4Q
MJ< -X:W8Q UCJP9Y&H&IB;16IMBC4Q%KE=/E5IG!%D0:*OKB6:KV08:2=K,!
MR\?WW6#O;2=XW7U7(SM'$EC@>U^G(%@Q/H:/,->_=MH[>V(,2GR<)9)AH1_2
M0DF[+<@\*DY&\HXV"W6O;*B)G=F5.^W][NQ*V #N+?;)/L"*8(9A%D-E RA'
MJ,$ 7V$E*11/%Q#$D(1PM6JH768EJ0+RP'M94:4BY@0E3&U,3#<;68W7@(6:
M( H47,.,;$*$!B JIDI:)P;6)'SE]W/3?L)8L2YX/FV0($T6GLI.(F-GO!M$
M9%+PEQRJ9#0*]<X,)E0VDQK1U.09($BCNI&(D8HCT9_RV=)OO#].8-E".Y>#
M!M [R8<00W1W.0)U6$6?S)U*^K"(=\7B9BVR].X!/='ZLZ!5QA@HVRS:'%\'
MR%0:,2NEPNGSTD58A>3>#EZF+H?6P%8Y=*JH9LL&MFPYE+('CF'87L-](#3&
M_GN=P(CC:;/!F3+QF3+ <W@8')4,@;$B1X/R*-X6V(Y5ZE3E("4E'R7"V+@B
M \^QH=T<%R9$,"9C@(W(/NRIV9BEIGV?F@+A\OY7'*$#=)F#][F!#-D'R1Z!
M(&#"D9)J:&"4G!I^AC;_[PO/V^+46.27,SGF%'=Q<48(28\XY:[[,,X=Q:CQ
MK&(9UN(?G+#$_47:+7,_ET1)PV1Z0T,8U+(U@$ED1$$%\7OL"SGDG H7K%L5
M:YE2E$J+S)2,V4HJ?YB+WU9]RY&(^'1!^7I&[R3DU<[^+B(4A4CLHY1=#TFS
M[<T&]L^*'J19ER.TD,U>*V^JKS?EUF9W:PTI8+ -G5ZI81Y[]L[)GY,\'DKV
M%BH,.,'Y; ;OC77(V93S4 VJ9B.6$Z3K$V1Q2]$YG@;><V8D&7BNBGP]4Q3&
M,S@3%%2IR2A0E'O!'FJNZLR_4DV,71-U-E4%O=8$;S9(!V4R79?(R?/3NC0_
MKC4VIQQ%YNS69F,1).$Q.C,I5BPN0S7"I5:1],*\C"\+R"U7C1[<,IW*(N.4
MR6^^ @4H"^)0E^9J)6C=="8C'8[F;N=D7>7I@8ZIFED#;25.#1_BKG</ =(A
M0#FK@OJ\6??.2E,N[O;1>ZG@8J17%YVS6DS42S%JTZ:S?.#A949\U^"(JJOC
MS1<]HB+D\LZD4"-,EB,%JI!$R91YHY!A'&6>_(6F^)5!D<M9[Z8JK70%XYBA
MMA"C O:X]<%#K(D==>4&LW*/+*"FZC7&4 LFU-UP.$'JLJ32[X@HXCD"2K-1
MBRCN\2%E#7(OT+8T58[4ZR!_*HILD<%YTA<**=\'<Z?GDS74X%0<!V7?#P7J
M$.6+QY)<K;:SGU- G):HKG?S /2X=(<3<ZKC"K4,%<$<%4Y$1;FP_G*$_%KQ
MD/).KS(<_XH'+M(^,>.A#[2LX8<(3DQ.W8V"R4/9@SRFQ&FL;YEJUHBE;SDT
M-("I>%QF_KA@,,0]TUW)VPIS6AZ&?;_R6YD9LP%4"WV3H8CFM;^<5SV>VBI>
M'\O!'.U?6BWQ7J.U/!"7*( /0>!;KE#J@0_1:A5CV:/S#_\NF:R3Z717T'E#
M:WT$.66KM5.4/[>BT]Z#:&0 $3AY$/A'"3/SXZ-M<+B"V;Y5\K;E>ZX#,68)
MZU>_67$U"55GK^;6&\=+Q&H ;A."'K2?K]6GL:OED><)=8^BF%^*VOCRB4G]
MO'R_($<UAA4\AZ4V\:'!*DWCRLFJ3E.#ZI[;R.4A:VV,NF[4ZCL.DZ2:"L=4
MQ9S=E0VY8<A@M0E/!\'M<,0C3TZ?ZE(2'P5):F,FTM?'Q&3,"9?:=J?LG0X)
M#9)9I91='5('V ./BH>>,N1B@ X7O)>R4!:1"4XXFB>&/ A!UY1I4! %OT@&
MB/#X'BL@)H<D-\A;_E#)622*.11\A7/RH159F@C.!*]@>\J,_XP.\MY8%&U1
MZ\*86Y+ZNBR87JB#+!4MJ%5H+.FH4&9)XT+2JC1TW!$5M29U!CPH1OXM._3N
MVY.'!P%L#-7N3F_%[K*YJAU['13U!0WA%H991<?EY !=$(IG)*3RO4J(I$#E
M, ]3C>/*@2V.AS^SFH%%0\6.RJDFJN&7!QEXF5L="""'KA2%22QHB,9,+4!6
M=,M\)(!+A'$>+2")<D=R?U V!_"VC">'3O_73U\SG:P8 ?)\T"V1K-]-')E!
MIE VZ32B$JI 02'.%&6X*Y&3.@E*Q,JE-$/I-L:QQ2=]%6M$@,7ED,JZQ44T
M[SP;75KG^66YVFP4RT,CX\6M%)+3I8MC?:O052VN H<2%!C'XF-T4(M+A@U)
M+XN#F)PN\3<VX"73RTS"BZC87%XV7]7RLANMPLK%*X!";!^JI0NH35]BCNOJ
M<B/W6K"=6%H:%I.35U/G.VFU]$Y0O"EKB_</6U(?P8%?.""JH/"A!U7_P?8P
M</Y%(^)][AM%3XL[ \IMOJ:7=Q(L4>,'UYW=Y4<.LFH<(Z[BZ?-BA&H+?FE:
MD(;KH4.@!ABYBMX14F<1:?*29H/L#H+&N+GH60V_:RSMNNR8'_8C"A,)M3T(
M)(X3?.7* 8="*IEB(.V['-_GH_>XQ4YZC\JO>?S@@/'@B$(Q@X9:D7*AU?VY
M4<-(20X)A5:O<)5X[_>7R@7?)K?TKIZDOU)C8PE"4F*"1-#Z@V=:T;K95;-1
MQ=?:[(K>)J$1BT5GC]\9[,T-;*NGW?WJ:1J5G" >.^XE,J(,[EV-=N^L+7[C
MO._!?B0X@9B:7'A7X3Z:QZH$5*[FAM1_I<+BQ:42;)LTZ1&FCQSJ+1)VF(_9
MWO@>?CN]]J+)R+].)F *JR,S39%P:U8>B$&>Y?2NZ,[G"^LEFVBG@G(B(UTY
MA.6P7!N)H*%](>70\W<*'\J7GU?*#_3=$U[>2Q",#H2V_S!QOXWT^X1W7XY,
MBBYTL]OI;J$D>M?:V=_9$;W_W(C=W=T?I_-@C_B\/RAZT:1K'?Q5'JM6V<6O
M&WJLI371438BWG?^MC%WFF1J4?F&A[7A"-^V8C)2\D=3AN+?^I1ACLF?#EX%
MVS;]'L__0(]^Q_<_4$L#!!0    (  R(5UPBB#H7) ,  - +   0    ;VQB
M+3(P,C8P,C$X+GAS9+55VW+:,!!][TS_0?6[;R0D@4 R"2D)*2D92#+AJ2-L
M0301DBO) ?KUE6S+7 P4:.LG>?><L[O2KE2[G(X)^$!<8$;KEN]X%D T8"&F
MH[KUW+.O>HU6RP*7%Y\_ ?75OM@V:&)$PBJX88'=HD-V#K[#,:J"6T01AY+Q
M<_ "2:PMK(D)XJ#!QA%!$BE'&JD*3IQC"&Q[!]D71$/&G[NM7/9-RDA477<R
MF3B4?< )X^_""=AX-\&>A#(6N9HW];)O-_H#%D%.KD"O+$ZG7?PZ0O0L?NC?
M=8,.C+\VX&-E>G_]ZUN?7(M;W[L+R<GI;#2^>^K<=V?E<O-*W/;[XBH-61/!
M&QI#H,Z"BKJEZ\O*FQPYC(_<DN?Y[NM#NY?@K!18G1),W]?!_4JEXB9> RT@
MIP-.C/21J]T#*%"NK+QX"QY3(2$-EO"AS F+X+*;.I>@>"WT)(5B PW1"DZ@
MP!FQ#U<Y%+Y4-L!8V",(HQP\A&*0B&:.);#@L@A4QE60+6<1$FNAJ6N)T&E?
MYU!&!KH;M?_$*_EG:J0(&B,JFXR/;] 0QD2E\#.&! \Q"BT@(1\AJ=M+1#!
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M&292^_!=*W,VLYMVJHE<%P31NZ:;UC2MRQWWYJ\BR>2>9WRSV;+R+H_MN4%
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M;.>.J20!X6'SU9%!1B"M]<+"8H,I_;Q-$T92>"(R5&Y9L%ILLM"0!,2"S1?
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MZA6@E7I&K*P"_:8J07DMMM\OKV^ZEI_D9KU)_K7"*9%;_@M02P,$%     @
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M9W)O=7 N:'1M4$L! A0#%     @ #(A77*SB(;])D0  J P# !X
M     ( !X!H  &5A,#(W-S<W,3 Q97@Q,"TQ7V]L8F=R;W5P+FAT;5!+ 0(4
M Q0    (  R(5US\G?X$[B@  "_(   >              "  66L  !E83 R
M-S<W-S$P,65X,3 M,E]O;&)G<F]U<"YH=&U02P$"% ,4    "  ,B%=<3;7!
M.898   N) ( '@              @ &/U0  96$P,C<W-S<Q,#%E>#$P+3-?
M;VQB9W)O=7 N:'1M4$L! A0#%     @ #(A77 ]_<=N%2P  )X0! !T
M         ( !42X! &5A,#(W-S<W,3 Q97@T+3%?;VQB9W)O=7 N:'1M4$L!
M A0#%     @ #(A77"3M"PSL1@  6(H! !T              ( !$7H! &5A
M,#(W-S<W,3 Q97@T+3)?;VQB9W)O=7 N:'1M4$L! A0#%     @ #(A77*0]
M[7KW"@  SB<  !X              ( !.,$! &5A,#(W-S<W,3 Q97@Y.2TQ
M7V]L8F=R;W5P+FAT;5!+ 0(4 Q0    (  R(5UPBB#H7) ,  - +   0
M          "  6O, 0!O;&(M,C R-C R,3@N>'-D4$L! A0#%     @ #(A7
M7%4: *#]"@  ?X8  !0              ( !O<\! &]L8BTR,#(V,#(Q.%]L
M86(N>&UL4$L! A0#%     @ #(A77,P.@/)6!P  R5<  !0
M ( ![-H! &]L8BTR,#(V,#(Q.%]P<F4N>&UL4$L%!@     *  H SP(  '3B
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea0277771-8k_olbgroup_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="olb-20260218.xsd" xlink:type="simple"/>
    <context id="AsOf2026-02-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001314196</identifier>
        </entity>
        <period>
            <startDate>2026-02-18</startDate>
            <endDate>2026-02-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-02-18" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-02-18" id="Fact000004">0001314196</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-02-18" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-02-18" id="Fact000010">2026-02-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-02-18" id="Fact000011">THE OLB GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-02-18" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-02-18" id="Fact000013">001-39435</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-02-18" id="Fact000014">12-4188568</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-02-18" id="Fact000015">1120 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-02-18" id="Fact000016">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-02-18" id="Fact000017">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-02-18" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-02-18" id="Fact000019">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-02-18" id="Fact000020">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-02-18" id="Fact000021">278-0900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-02-18" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-02-18" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-02-18" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-02-18" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-02-18" id="Fact000026">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-02-18" id="Fact000027">OLB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-02-18" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-02-18" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2026-02-18" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
